| 5.2 |
20.8 |
GO:0044268 |
multicellular organismal protein metabolic process(GO:0044268) |
| 5.2 |
20.8 |
GO:1905167 |
positive regulation of lysosomal protein catabolic process(GO:1905167) |
| 4.6 |
13.8 |
GO:0048687 |
positive regulation of sprouting of injured axon(GO:0048687) positive regulation of axon extension involved in regeneration(GO:0048691) |
| 4.6 |
13.7 |
GO:0015910 |
peroxisomal long-chain fatty acid import(GO:0015910) |
| 4.1 |
16.4 |
GO:1904048 |
regulation of spontaneous neurotransmitter secretion(GO:1904048) |
| 4.0 |
12.1 |
GO:0030827 |
negative regulation of cGMP metabolic process(GO:0030824) negative regulation of cGMP biosynthetic process(GO:0030827) negative regulation of guanylate cyclase activity(GO:0031283) |
| 3.9 |
3.9 |
GO:1901897 |
regulation of relaxation of cardiac muscle(GO:1901897) |
| 3.8 |
11.4 |
GO:0002030 |
inhibitory G-protein coupled receptor phosphorylation(GO:0002030) |
| 3.8 |
11.3 |
GO:0099548 |
trans-synaptic signaling by nitric oxide(GO:0099548) |
| 3.6 |
10.9 |
GO:0043988 |
histone H3-S28 phosphorylation(GO:0043988) |
| 3.6 |
10.7 |
GO:0071317 |
cellular response to isoquinoline alkaloid(GO:0071317) |
| 3.5 |
10.6 |
GO:0038095 |
Fc-epsilon receptor signaling pathway(GO:0038095) |
| 3.4 |
20.5 |
GO:0030643 |
cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
| 3.3 |
9.8 |
GO:0018103 |
protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
| 3.2 |
22.6 |
GO:0060762 |
regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
| 3.1 |
9.2 |
GO:2000344 |
positive regulation of acrosome reaction(GO:2000344) |
| 3.1 |
12.3 |
GO:0016340 |
calcium-dependent cell-matrix adhesion(GO:0016340) |
| 3.1 |
9.2 |
GO:0003349 |
epicardium-derived cardiac endothelial cell differentiation(GO:0003349) |
| 2.9 |
8.7 |
GO:0021837 |
motogenic signaling involved in postnatal olfactory bulb interneuron migration(GO:0021837) positive regulation of mitotic cell cycle DNA replication(GO:1903465) |
| 2.9 |
25.9 |
GO:0032484 |
Ral protein signal transduction(GO:0032484) |
| 2.8 |
11.4 |
GO:0043974 |
histone H3-K27 acetylation(GO:0043974) regulation of histone H3-K27 acetylation(GO:1901674) |
| 2.8 |
14.1 |
GO:0010991 |
negative regulation of SMAD protein complex assembly(GO:0010991) |
| 2.8 |
5.6 |
GO:1903181 |
regulation of dopamine biosynthetic process(GO:1903179) positive regulation of dopamine biosynthetic process(GO:1903181) |
| 2.7 |
8.2 |
GO:0003357 |
noradrenergic neuron differentiation(GO:0003357) |
| 2.7 |
2.7 |
GO:0060489 |
orthogonal dichotomous subdivision of terminal units involved in lung branching morphogenesis(GO:0060488) planar dichotomous subdivision of terminal units involved in lung branching morphogenesis(GO:0060489) lateral sprouting involved in lung morphogenesis(GO:0060490) |
| 2.6 |
7.7 |
GO:0097155 |
fasciculation of sensory neuron axon(GO:0097155) |
| 2.6 |
10.2 |
GO:2000017 |
positive regulation of determination of dorsal identity(GO:2000017) |
| 2.5 |
7.6 |
GO:0046168 |
glycerol-3-phosphate catabolic process(GO:0046168) |
| 2.5 |
2.5 |
GO:0060399 |
positive regulation of growth hormone receptor signaling pathway(GO:0060399) |
| 2.5 |
7.6 |
GO:0006601 |
creatine biosynthetic process(GO:0006601) |
| 2.5 |
2.5 |
GO:0015816 |
glycine transport(GO:0015816) |
| 2.4 |
12.2 |
GO:0015871 |
choline transport(GO:0015871) |
| 2.4 |
19.5 |
GO:0016338 |
calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
| 2.4 |
7.3 |
GO:0072223 |
metanephric glomerular mesangium development(GO:0072223) metanephric glomerular mesangial cell proliferation involved in metanephros development(GO:0072262) |
| 2.4 |
2.4 |
GO:1904352 |
positive regulation of protein catabolic process in the vacuole(GO:1904352) |
| 2.4 |
12.0 |
GO:0007256 |
activation of JNKK activity(GO:0007256) |
| 2.4 |
4.7 |
GO:0097494 |
regulation of vesicle size(GO:0097494) |
| 2.3 |
6.9 |
GO:0050925 |
negative regulation of negative chemotaxis(GO:0050925) |
| 2.3 |
22.6 |
GO:0010459 |
negative regulation of heart rate(GO:0010459) |
| 2.2 |
19.8 |
GO:0050908 |
detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
| 2.2 |
2.2 |
GO:0046619 |
optic placode formation involved in camera-type eye formation(GO:0046619) |
| 2.2 |
10.8 |
GO:0051684 |
maintenance of Golgi location(GO:0051684) |
| 2.1 |
6.4 |
GO:0051542 |
elastin biosynthetic process(GO:0051542) |
| 2.1 |
6.4 |
GO:0031554 |
regulation of DNA-templated transcription, termination(GO:0031554) |
| 2.1 |
8.5 |
GO:0035609 |
C-terminal protein deglutamylation(GO:0035609) |
| 2.1 |
8.4 |
GO:2000525 |
regulation of T cell costimulation(GO:2000523) positive regulation of T cell costimulation(GO:2000525) |
| 2.0 |
8.1 |
GO:0021564 |
glossopharyngeal nerve development(GO:0021563) vagus nerve development(GO:0021564) |
| 2.0 |
12.1 |
GO:2000298 |
regulation of Rho-dependent protein serine/threonine kinase activity(GO:2000298) |
| 2.0 |
6.0 |
GO:0019074 |
viral genome packaging(GO:0019072) viral RNA genome packaging(GO:0019074) |
| 2.0 |
8.0 |
GO:1903977 |
positive regulation of glial cell migration(GO:1903977) |
| 2.0 |
10.0 |
GO:0034441 |
plasma lipoprotein particle oxidation(GO:0034441) |
| 2.0 |
9.9 |
GO:0070327 |
thyroid hormone transport(GO:0070327) |
| 2.0 |
7.9 |
GO:0043490 |
malate-aspartate shuttle(GO:0043490) |
| 2.0 |
5.9 |
GO:1902022 |
L-lysine transport(GO:1902022) |
| 2.0 |
3.9 |
GO:0044331 |
cell-cell adhesion mediated by cadherin(GO:0044331) |
| 1.9 |
7.8 |
GO:0098884 |
postsynaptic neurotransmitter receptor internalization(GO:0098884) |
| 1.9 |
5.8 |
GO:0060854 |
patterning of lymph vessels(GO:0060854) |
| 1.9 |
7.6 |
GO:0009597 |
detection of virus(GO:0009597) |
| 1.9 |
9.5 |
GO:0070417 |
cellular response to cold(GO:0070417) |
| 1.9 |
30.3 |
GO:0021902 |
commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
| 1.9 |
15.1 |
GO:0090336 |
positive regulation of brown fat cell differentiation(GO:0090336) |
| 1.9 |
1.9 |
GO:0072554 |
blood vessel lumenization(GO:0072554) |
| 1.9 |
5.6 |
GO:1903002 |
regulation of lipid transport across blood brain barrier(GO:1903000) positive regulation of lipid transport across blood brain barrier(GO:1903002) |
| 1.8 |
5.5 |
GO:0038165 |
oncostatin-M-mediated signaling pathway(GO:0038165) |
| 1.8 |
20.2 |
GO:0055003 |
cardiac myofibril assembly(GO:0055003) |
| 1.8 |
7.3 |
GO:1903288 |
positive regulation of potassium ion import(GO:1903288) |
| 1.8 |
9.0 |
GO:0035405 |
histone-threonine phosphorylation(GO:0035405) |
| 1.8 |
9.0 |
GO:0070305 |
response to cGMP(GO:0070305) cellular response to cGMP(GO:0071321) |
| 1.8 |
7.2 |
GO:0045054 |
constitutive secretory pathway(GO:0045054) |
| 1.8 |
16.1 |
GO:0060662 |
tube lumen cavitation(GO:0060605) salivary gland cavitation(GO:0060662) |
| 1.8 |
8.9 |
GO:0010985 |
negative regulation of lipoprotein particle clearance(GO:0010985) |
| 1.8 |
7.1 |
GO:2000211 |
regulation of glutamate metabolic process(GO:2000211) |
| 1.8 |
10.7 |
GO:0032483 |
regulation of Rab protein signal transduction(GO:0032483) |
| 1.8 |
7.1 |
GO:0003430 |
growth plate cartilage chondrocyte growth(GO:0003430) |
| 1.8 |
8.8 |
GO:1900170 |
negative regulation of glucocorticoid mediated signaling pathway(GO:1900170) |
| 1.8 |
3.5 |
GO:0032489 |
regulation of Cdc42 protein signal transduction(GO:0032489) |
| 1.8 |
5.3 |
GO:1904742 |
regulation of telomeric DNA binding(GO:1904742) |
| 1.8 |
3.5 |
GO:1903978 |
regulation of microglial cell activation(GO:1903978) |
| 1.7 |
5.2 |
GO:0032915 |
positive regulation of transforming growth factor beta2 production(GO:0032915) |
| 1.7 |
6.9 |
GO:0097343 |
ripoptosome assembly(GO:0097343) ripoptosome assembly involved in necroptotic process(GO:1901026) |
| 1.7 |
5.1 |
GO:0072034 |
renal vesicle induction(GO:0072034) |
| 1.7 |
11.9 |
GO:0014053 |
negative regulation of gamma-aminobutyric acid secretion(GO:0014053) |
| 1.7 |
5.1 |
GO:0046881 |
positive regulation of follicle-stimulating hormone secretion(GO:0046881) |
| 1.7 |
5.1 |
GO:0019482 |
beta-alanine metabolic process(GO:0019482) |
| 1.7 |
17.0 |
GO:0021869 |
forebrain ventricular zone progenitor cell division(GO:0021869) |
| 1.7 |
5.0 |
GO:0032242 |
regulation of nucleoside transport(GO:0032242) |
| 1.7 |
5.0 |
GO:1904179 |
positive regulation of adipose tissue development(GO:1904179) |
| 1.7 |
6.6 |
GO:0007066 |
female meiosis sister chromatid cohesion(GO:0007066) |
| 1.6 |
4.9 |
GO:1905000 |
regulation of membrane repolarization during atrial cardiac muscle cell action potential(GO:1905000) |
| 1.6 |
4.9 |
GO:0090271 |
positive regulation of fibroblast growth factor production(GO:0090271) |
| 1.6 |
1.6 |
GO:0021764 |
amygdala development(GO:0021764) |
| 1.6 |
9.8 |
GO:0003383 |
apical constriction(GO:0003383) |
| 1.6 |
1.6 |
GO:0098917 |
retrograde trans-synaptic signaling(GO:0098917) |
| 1.6 |
6.5 |
GO:0048842 |
positive regulation of axon extension involved in axon guidance(GO:0048842) |
| 1.6 |
6.5 |
GO:0097298 |
regulation of nucleus size(GO:0097298) |
| 1.6 |
11.4 |
GO:0001542 |
ovulation from ovarian follicle(GO:0001542) |
| 1.6 |
1.6 |
GO:0048168 |
regulation of neuronal synaptic plasticity(GO:0048168) |
| 1.6 |
1.6 |
GO:0051541 |
elastin metabolic process(GO:0051541) |
| 1.6 |
8.1 |
GO:0034162 |
toll-like receptor 9 signaling pathway(GO:0034162) |
| 1.6 |
6.4 |
GO:0015817 |
histidine transport(GO:0015817) |
| 1.6 |
8.0 |
GO:0051012 |
microtubule sliding(GO:0051012) |
| 1.6 |
17.5 |
GO:1902474 |
positive regulation of protein localization to synapse(GO:1902474) |
| 1.6 |
9.5 |
GO:0007021 |
tubulin complex assembly(GO:0007021) |
| 1.5 |
7.7 |
GO:1901525 |
negative regulation of macromitophagy(GO:1901525) |
| 1.5 |
4.6 |
GO:0051562 |
negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
| 1.5 |
12.3 |
GO:0021815 |
modulation of microtubule cytoskeleton involved in cerebral cortex radial glia guided migration(GO:0021815) |
| 1.5 |
7.7 |
GO:0010701 |
positive regulation of norepinephrine secretion(GO:0010701) |
| 1.5 |
4.6 |
GO:0033364 |
mast cell secretory granule organization(GO:0033364) |
| 1.5 |
7.6 |
GO:0030205 |
dermatan sulfate metabolic process(GO:0030205) |
| 1.5 |
4.5 |
GO:1902630 |
regulation of membrane hyperpolarization(GO:1902630) |
| 1.5 |
4.5 |
GO:0018008 |
N-terminal peptidyl-glycine N-myristoylation(GO:0018008) |
| 1.5 |
1.5 |
GO:0006642 |
triglyceride mobilization(GO:0006642) |
| 1.5 |
9.1 |
GO:1903056 |
positive regulation of lens fiber cell differentiation(GO:1902748) regulation of melanosome organization(GO:1903056) |
| 1.5 |
6.0 |
GO:0010891 |
negative regulation of sequestering of triglyceride(GO:0010891) |
| 1.5 |
4.5 |
GO:0001951 |
intestinal D-glucose absorption(GO:0001951) terminal web assembly(GO:1902896) |
| 1.5 |
10.4 |
GO:0007342 |
fusion of sperm to egg plasma membrane(GO:0007342) |
| 1.5 |
8.9 |
GO:0042276 |
error-prone translesion synthesis(GO:0042276) |
| 1.5 |
5.9 |
GO:0036015 |
response to interleukin-3(GO:0036015) cellular response to interleukin-3(GO:0036016) |
| 1.5 |
2.9 |
GO:0001978 |
regulation of systemic arterial blood pressure by carotid sinus baroreceptor feedback(GO:0001978) |
| 1.5 |
7.3 |
GO:0015803 |
branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
| 1.5 |
4.4 |
GO:0051933 |
amino acid neurotransmitter reuptake(GO:0051933) glutamate reuptake(GO:0051935) |
| 1.5 |
5.9 |
GO:0051964 |
negative regulation of synapse assembly(GO:0051964) |
| 1.5 |
7.3 |
GO:2000427 |
positive regulation of apoptotic cell clearance(GO:2000427) |
| 1.5 |
4.4 |
GO:0015866 |
ADP transport(GO:0015866) |
| 1.4 |
2.9 |
GO:0010808 |
positive regulation of synaptic vesicle priming(GO:0010808) |
| 1.4 |
13.0 |
GO:0031339 |
negative regulation of vesicle fusion(GO:0031339) |
| 1.4 |
7.2 |
GO:0070100 |
negative regulation of chemokine-mediated signaling pathway(GO:0070100) |
| 1.4 |
14.2 |
GO:0042118 |
endothelial cell activation(GO:0042118) |
| 1.4 |
1.4 |
GO:0060667 |
fibroblast growth factor receptor signaling pathway involved in mammary gland specification(GO:0060595) mammary gland bud formation(GO:0060615) branch elongation involved in salivary gland morphogenesis(GO:0060667) mesenchymal cell differentiation involved in lung development(GO:0060915) |
| 1.4 |
2.8 |
GO:0072602 |
interleukin-4 secretion(GO:0072602) |
| 1.4 |
1.4 |
GO:0021523 |
somatic motor neuron differentiation(GO:0021523) |
| 1.4 |
2.8 |
GO:1901204 |
regulation of adrenergic receptor signaling pathway involved in heart process(GO:1901204) |
| 1.4 |
2.8 |
GO:0048702 |
embryonic neurocranium morphogenesis(GO:0048702) |
| 1.4 |
4.2 |
GO:1902528 |
regulation of protein linear polyubiquitination(GO:1902528) positive regulation of protein linear polyubiquitination(GO:1902530) |
| 1.4 |
5.6 |
GO:0007195 |
adenylate cyclase-inhibiting dopamine receptor signaling pathway(GO:0007195) |
| 1.4 |
4.2 |
GO:0036091 |
positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
| 1.4 |
11.1 |
GO:0036444 |
calcium ion transmembrane import into mitochondrion(GO:0036444) |
| 1.4 |
11.0 |
GO:0072321 |
chaperone-mediated protein transport(GO:0072321) |
| 1.4 |
4.1 |
GO:0031117 |
positive regulation of microtubule depolymerization(GO:0031117) |
| 1.3 |
20.2 |
GO:0032793 |
positive regulation of CREB transcription factor activity(GO:0032793) |
| 1.3 |
1.3 |
GO:0003274 |
endocardial cushion fusion(GO:0003274) |
| 1.3 |
1.3 |
GO:0010694 |
positive regulation of alkaline phosphatase activity(GO:0010694) |
| 1.3 |
2.7 |
GO:0061502 |
early endosome to recycling endosome transport(GO:0061502) |
| 1.3 |
1.3 |
GO:0071680 |
response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
| 1.3 |
5.3 |
GO:0000415 |
negative regulation of histone H3-K36 methylation(GO:0000415) |
| 1.3 |
5.3 |
GO:0010735 |
positive regulation of transcription via serum response element binding(GO:0010735) |
| 1.3 |
3.9 |
GO:0033601 |
positive regulation of mammary gland epithelial cell proliferation(GO:0033601) |
| 1.3 |
3.9 |
GO:0043379 |
memory T cell differentiation(GO:0043379) |
| 1.3 |
5.2 |
GO:0007158 |
neuron cell-cell adhesion(GO:0007158) |
| 1.3 |
5.2 |
GO:0061092 |
regulation of phospholipid translocation(GO:0061091) positive regulation of phospholipid translocation(GO:0061092) |
| 1.3 |
5.2 |
GO:0090472 |
dibasic protein processing(GO:0090472) |
| 1.3 |
18.1 |
GO:0007252 |
I-kappaB phosphorylation(GO:0007252) |
| 1.3 |
18.0 |
GO:0034497 |
protein localization to pre-autophagosomal structure(GO:0034497) |
| 1.3 |
5.1 |
GO:0060054 |
positive regulation of epithelial cell proliferation involved in wound healing(GO:0060054) |
| 1.3 |
6.4 |
GO:0035745 |
T-helper 2 cell cytokine production(GO:0035745) |
| 1.3 |
5.1 |
GO:0032808 |
lacrimal gland development(GO:0032808) |
| 1.3 |
6.4 |
GO:0070164 |
negative regulation of adiponectin secretion(GO:0070164) |
| 1.3 |
2.5 |
GO:0043323 |
positive regulation of natural killer cell degranulation(GO:0043323) |
| 1.3 |
1.3 |
GO:0021631 |
optic nerve morphogenesis(GO:0021631) |
| 1.3 |
8.9 |
GO:1900042 |
positive regulation of interleukin-2 secretion(GO:1900042) |
| 1.3 |
6.3 |
GO:0072368 |
regulation of lipid transport by negative regulation of transcription from RNA polymerase II promoter(GO:0072368) |
| 1.3 |
7.6 |
GO:0097473 |
cellular response to light intensity(GO:0071484) cellular response to high light intensity(GO:0071486) retinal rod cell apoptotic process(GO:0097473) |
| 1.2 |
5.0 |
GO:0032229 |
negative regulation of synaptic transmission, GABAergic(GO:0032229) |
| 1.2 |
2.5 |
GO:0034380 |
high-density lipoprotein particle assembly(GO:0034380) |
| 1.2 |
6.2 |
GO:1900748 |
positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
| 1.2 |
3.7 |
GO:0018214 |
peptidyl-glutamic acid carboxylation(GO:0017187) protein carboxylation(GO:0018214) |
| 1.2 |
3.7 |
GO:1902605 |
heterotrimeric G-protein complex assembly(GO:1902605) |
| 1.2 |
20.8 |
GO:0048172 |
regulation of short-term neuronal synaptic plasticity(GO:0048172) |
| 1.2 |
1.2 |
GO:1900673 |
olefin metabolic process(GO:1900673) |
| 1.2 |
3.7 |
GO:0090403 |
oxidative stress-induced premature senescence(GO:0090403) |
| 1.2 |
3.6 |
GO:0060447 |
bud outgrowth involved in lung branching(GO:0060447) |
| 1.2 |
9.6 |
GO:0061072 |
iris morphogenesis(GO:0061072) |
| 1.2 |
7.2 |
GO:2000672 |
negative regulation of motor neuron apoptotic process(GO:2000672) |
| 1.2 |
4.8 |
GO:0036515 |
serotonergic neuron axon guidance(GO:0036515) |
| 1.2 |
3.6 |
GO:0002447 |
eosinophil activation involved in immune response(GO:0002278) eosinophil mediated immunity(GO:0002447) eosinophil degranulation(GO:0043308) |
| 1.2 |
3.6 |
GO:0036363 |
transforming growth factor beta activation(GO:0036363) |
| 1.2 |
3.6 |
GO:0007352 |
zygotic specification of dorsal/ventral axis(GO:0007352) |
| 1.2 |
3.5 |
GO:0070428 |
regulation of nucleotide-binding oligomerization domain containing signaling pathway(GO:0070424) regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070428) regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070432) |
| 1.2 |
3.5 |
GO:0051611 |
negative regulation of neurotransmitter uptake(GO:0051581) serotonin uptake(GO:0051610) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
| 1.2 |
3.5 |
GO:0033689 |
negative regulation of osteoblast proliferation(GO:0033689) |
| 1.2 |
3.5 |
GO:0046208 |
spermine catabolic process(GO:0046208) |
| 1.2 |
12.8 |
GO:1903818 |
positive regulation of voltage-gated potassium channel activity(GO:1903818) |
| 1.2 |
2.3 |
GO:0007228 |
positive regulation of hh target transcription factor activity(GO:0007228) |
| 1.2 |
3.5 |
GO:0010641 |
positive regulation of platelet-derived growth factor receptor signaling pathway(GO:0010641) |
| 1.2 |
1.2 |
GO:0099525 |
presynaptic dense core granule exocytosis(GO:0099525) |
| 1.2 |
1.2 |
GO:1904778 |
regulation of protein localization to cell cortex(GO:1904776) positive regulation of protein localization to cell cortex(GO:1904778) |
| 1.2 |
11.5 |
GO:0046959 |
habituation(GO:0046959) |
| 1.1 |
3.4 |
GO:0042756 |
drinking behavior(GO:0042756) |
| 1.1 |
2.3 |
GO:0071677 |
positive regulation of mononuclear cell migration(GO:0071677) |
| 1.1 |
2.3 |
GO:0051646 |
mitochondrion localization(GO:0051646) |
| 1.1 |
15.9 |
GO:0009437 |
carnitine metabolic process(GO:0009437) |
| 1.1 |
5.7 |
GO:0035493 |
SNARE complex assembly(GO:0035493) |
| 1.1 |
5.6 |
GO:0010724 |
regulation of definitive erythrocyte differentiation(GO:0010724) |
| 1.1 |
4.5 |
GO:0031581 |
hemidesmosome assembly(GO:0031581) |
| 1.1 |
2.2 |
GO:0071211 |
protein targeting to vacuole involved in autophagy(GO:0071211) |
| 1.1 |
3.3 |
GO:0060074 |
synapse maturation(GO:0060074) |
| 1.1 |
7.8 |
GO:0038028 |
insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
| 1.1 |
3.3 |
GO:0007525 |
somatic muscle development(GO:0007525) |
| 1.1 |
2.2 |
GO:0032227 |
negative regulation of synaptic transmission, dopaminergic(GO:0032227) |
| 1.1 |
7.6 |
GO:0016480 |
negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
| 1.1 |
3.3 |
GO:0035621 |
ER to Golgi ceramide transport(GO:0035621) ceramide transport(GO:0035627) |
| 1.1 |
7.6 |
GO:0060050 |
positive regulation of protein glycosylation(GO:0060050) |
| 1.1 |
2.2 |
GO:0035624 |
receptor transactivation(GO:0035624) epidermal growth factor-activated receptor transactivation by G-protein coupled receptor signaling pathway(GO:0035625) |
| 1.1 |
7.5 |
GO:1990118 |
sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
| 1.1 |
10.6 |
GO:0060081 |
membrane hyperpolarization(GO:0060081) |
| 1.1 |
1.1 |
GO:0090494 |
catecholamine uptake(GO:0090493) dopamine uptake(GO:0090494) |
| 1.1 |
2.1 |
GO:0001956 |
positive regulation of neurotransmitter secretion(GO:0001956) |
| 1.1 |
10.6 |
GO:1902036 |
regulation of hematopoietic stem cell differentiation(GO:1902036) |
| 1.1 |
1.1 |
GO:0042160 |
lipoprotein modification(GO:0042160) lipoprotein oxidation(GO:0042161) |
| 1.1 |
3.2 |
GO:0097500 |
receptor localization to nonmotile primary cilium(GO:0097500) |
| 1.0 |
4.2 |
GO:2000671 |
regulation of motor neuron apoptotic process(GO:2000671) |
| 1.0 |
11.5 |
GO:0097011 |
cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) response to granulocyte macrophage colony-stimulating factor(GO:0097012) |
| 1.0 |
1.0 |
GO:0006701 |
progesterone biosynthetic process(GO:0006701) |
| 1.0 |
2.1 |
GO:0045838 |
positive regulation of membrane potential(GO:0045838) |
| 1.0 |
3.1 |
GO:0017055 |
negative regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0017055) |
| 1.0 |
11.2 |
GO:2000480 |
regulation of cAMP-dependent protein kinase activity(GO:2000479) negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
| 1.0 |
15.3 |
GO:0021684 |
cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
| 1.0 |
2.0 |
GO:0042939 |
glutathione transport(GO:0034635) tripeptide transport(GO:0042939) |
| 1.0 |
1.0 |
GO:0090188 |
negative regulation of pancreatic juice secretion(GO:0090188) |
| 1.0 |
2.0 |
GO:0010693 |
negative regulation of alkaline phosphatase activity(GO:0010693) |
| 1.0 |
2.0 |
GO:0048143 |
astrocyte activation(GO:0048143) |
| 1.0 |
3.0 |
GO:0018125 |
peptidyl-cysteine methylation(GO:0018125) |
| 1.0 |
6.0 |
GO:0070294 |
renal sodium ion transport(GO:0003096) renal sodium ion absorption(GO:0070294) |
| 1.0 |
1.0 |
GO:0035871 |
protein K11-linked deubiquitination(GO:0035871) |
| 1.0 |
8.0 |
GO:0071802 |
negative regulation of podosome assembly(GO:0071802) |
| 1.0 |
8.9 |
GO:0098937 |
dendritic transport(GO:0098935) anterograde dendritic transport(GO:0098937) |
| 1.0 |
2.0 |
GO:0008582 |
regulation of synaptic growth at neuromuscular junction(GO:0008582) |
| 1.0 |
3.9 |
GO:0097393 |
negative regulation of maintenance of sister chromatid cohesion(GO:0034092) negative regulation of maintenance of mitotic sister chromatid cohesion(GO:0034183) post-embryonic appendage morphogenesis(GO:0035120) post-embryonic limb morphogenesis(GO:0035127) post-embryonic forelimb morphogenesis(GO:0035128) telomeric repeat-containing RNA transcription(GO:0097393) telomeric repeat-containing RNA transcription from RNA pol II promoter(GO:0097394) maintenance of mitotic sister chromatid cohesion, telomeric(GO:0099403) mitotic sister chromatid cohesion, telomeric(GO:0099404) regulation of telomeric RNA transcription from RNA pol II promoter(GO:1901580) negative regulation of telomeric RNA transcription from RNA pol II promoter(GO:1901581) positive regulation of telomeric RNA transcription from RNA pol II promoter(GO:1901582) regulation of maintenance of mitotic sister chromatid cohesion, telomeric(GO:1904907) negative regulation of maintenance of mitotic sister chromatid cohesion, telomeric(GO:1904908) |
| 1.0 |
2.9 |
GO:0061031 |
endodermal digestive tract morphogenesis(GO:0061031) |
| 1.0 |
3.9 |
GO:2000048 |
negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
| 1.0 |
2.9 |
GO:0061428 |
negative regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061428) |
| 1.0 |
4.8 |
GO:0060665 |
regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling(GO:0060665) |
| 1.0 |
1.0 |
GO:0014809 |
regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion(GO:0014809) |
| 1.0 |
5.8 |
GO:0003350 |
pulmonary myocardium development(GO:0003350) |
| 1.0 |
1.9 |
GO:0042758 |
long-chain fatty acid catabolic process(GO:0042758) |
| 1.0 |
1.9 |
GO:0002069 |
columnar/cuboidal epithelial cell maturation(GO:0002069) |
| 1.0 |
1.9 |
GO:0007621 |
negative regulation of female receptivity(GO:0007621) |
| 1.0 |
4.8 |
GO:0090005 |
negative regulation of Golgi to plasma membrane protein transport(GO:0042997) negative regulation of establishment of protein localization to plasma membrane(GO:0090005) |
| 1.0 |
1.9 |
GO:0048294 |
negative regulation of isotype switching to IgE isotypes(GO:0048294) |
| 1.0 |
6.7 |
GO:0034058 |
endosomal vesicle fusion(GO:0034058) |
| 1.0 |
2.9 |
GO:0008626 |
granzyme-mediated apoptotic signaling pathway(GO:0008626) |
| 1.0 |
4.8 |
GO:2000465 |
regulation of glycogen (starch) synthase activity(GO:2000465) |
| 1.0 |
2.9 |
GO:0045204 |
MAPK export from nucleus(GO:0045204) |
| 0.9 |
3.8 |
GO:1904425 |
negative regulation of GTP binding(GO:1904425) |
| 0.9 |
0.9 |
GO:2000812 |
regulation of barbed-end actin filament capping(GO:2000812) |
| 0.9 |
3.8 |
GO:1904936 |
cerebral cortex GABAergic interneuron migration(GO:0021853) interneuron migration(GO:1904936) |
| 0.9 |
4.7 |
GO:0038032 |
termination of G-protein coupled receptor signaling pathway(GO:0038032) |
| 0.9 |
4.7 |
GO:0032226 |
positive regulation of synaptic transmission, dopaminergic(GO:0032226) |
| 0.9 |
2.8 |
GO:0097049 |
motor neuron apoptotic process(GO:0097049) |
| 0.9 |
4.6 |
GO:0071692 |
protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) |
| 0.9 |
4.6 |
GO:0002726 |
positive regulation of T cell cytokine production(GO:0002726) |
| 0.9 |
16.6 |
GO:0014047 |
glutamate secretion(GO:0014047) |
| 0.9 |
4.6 |
GO:0032482 |
Rab protein signal transduction(GO:0032482) |
| 0.9 |
4.6 |
GO:0032237 |
activation of store-operated calcium channel activity(GO:0032237) |
| 0.9 |
0.9 |
GO:0021830 |
substrate-independent telencephalic tangential migration(GO:0021826) interneuron migration from the subpallium to the cortex(GO:0021830) substrate-independent telencephalic tangential interneuron migration(GO:0021843) |
| 0.9 |
11.0 |
GO:2000821 |
regulation of grooming behavior(GO:2000821) |
| 0.9 |
2.7 |
GO:0046416 |
D-amino acid metabolic process(GO:0046416) |
| 0.9 |
3.6 |
GO:0071596 |
ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
| 0.9 |
1.8 |
GO:0070375 |
ERK5 cascade(GO:0070375) |
| 0.9 |
2.7 |
GO:1902473 |
regulation of protein localization to synapse(GO:1902473) |
| 0.9 |
1.8 |
GO:0043031 |
negative regulation of macrophage activation(GO:0043031) |
| 0.9 |
2.7 |
GO:0014889 |
muscle atrophy(GO:0014889) |
| 0.9 |
1.8 |
GO:1903903 |
regulation of establishment of T cell polarity(GO:1903903) |
| 0.9 |
1.8 |
GO:0051599 |
response to hydrostatic pressure(GO:0051599) |
| 0.9 |
2.7 |
GO:0031161 |
phosphatidylinositol catabolic process(GO:0031161) |
| 0.9 |
6.2 |
GO:0030969 |
mRNA splicing via endonucleolytic cleavage and ligation involved in unfolded protein response(GO:0030969) mRNA splicing, via endonucleolytic cleavage and ligation(GO:0070054) mRNA endonucleolytic cleavage involved in unfolded protein response(GO:0070055) |
| 0.9 |
5.3 |
GO:0010624 |
regulation of Schwann cell proliferation(GO:0010624) |
| 0.9 |
0.9 |
GO:0045581 |
negative regulation of T cell differentiation(GO:0045581) |
| 0.9 |
2.6 |
GO:0097151 |
positive regulation of inhibitory postsynaptic potential(GO:0097151) |
| 0.9 |
0.9 |
GO:0070885 |
negative regulation of calcineurin-NFAT signaling cascade(GO:0070885) |
| 0.9 |
0.9 |
GO:0036482 |
neuron intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:0036482) positive regulation of mitochondrial electron transport, NADH to ubiquinone(GO:1902958) regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway(GO:1903383) negative regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway(GO:1903384) |
| 0.9 |
2.6 |
GO:0098928 |
presynaptic signal transduction(GO:0098928) presynapse to nucleus signaling pathway(GO:0099526) |
| 0.9 |
18.3 |
GO:0021859 |
pyramidal neuron differentiation(GO:0021859) |
| 0.9 |
0.9 |
GO:0070343 |
white fat cell proliferation(GO:0070343) regulation of white fat cell proliferation(GO:0070350) |
| 0.9 |
3.5 |
GO:0014866 |
skeletal myofibril assembly(GO:0014866) |
| 0.9 |
4.3 |
GO:2000189 |
positive regulation of cholesterol homeostasis(GO:2000189) |
| 0.9 |
2.6 |
GO:1904504 |
regulation of lipophagy(GO:1904502) positive regulation of lipophagy(GO:1904504) |
| 0.9 |
2.6 |
GO:1990743 |
protein sialylation(GO:1990743) |
| 0.9 |
0.9 |
GO:0061010 |
gall bladder development(GO:0061010) |
| 0.9 |
4.3 |
GO:0003157 |
endocardium development(GO:0003157) |
| 0.9 |
0.9 |
GO:2000807 |
regulation of synaptic vesicle clustering(GO:2000807) |
| 0.9 |
2.6 |
GO:0098528 |
skeletal muscle fiber differentiation(GO:0098528) |
| 0.9 |
6.0 |
GO:0015862 |
uridine transport(GO:0015862) |
| 0.9 |
6.0 |
GO:0045956 |
positive regulation of calcium ion-dependent exocytosis(GO:0045956) |
| 0.8 |
0.8 |
GO:0035441 |
cell migration involved in vasculogenesis(GO:0035441) |
| 0.8 |
3.4 |
GO:0003256 |
regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation(GO:0003256) |
| 0.8 |
5.1 |
GO:0003273 |
cell migration involved in endocardial cushion formation(GO:0003273) |
| 0.8 |
6.8 |
GO:0000042 |
protein targeting to Golgi(GO:0000042) |
| 0.8 |
19.4 |
GO:0032933 |
response to sterol depletion(GO:0006991) SREBP signaling pathway(GO:0032933) cellular response to sterol depletion(GO:0071501) |
| 0.8 |
2.5 |
GO:1905034 |
regulation of antifungal innate immune response(GO:1905034) negative regulation of antifungal innate immune response(GO:1905035) |
| 0.8 |
2.5 |
GO:0009644 |
response to high light intensity(GO:0009644) |
| 0.8 |
5.9 |
GO:0030382 |
sperm mitochondrion organization(GO:0030382) |
| 0.8 |
1.7 |
GO:0061763 |
multivesicular body-lysosome fusion(GO:0061763) |
| 0.8 |
14.2 |
GO:0070544 |
histone H3-K36 demethylation(GO:0070544) |
| 0.8 |
7.5 |
GO:0001574 |
ganglioside biosynthetic process(GO:0001574) |
| 0.8 |
4.2 |
GO:0048149 |
behavioral response to ethanol(GO:0048149) |
| 0.8 |
2.5 |
GO:0032918 |
polyamine acetylation(GO:0032917) spermidine acetylation(GO:0032918) |
| 0.8 |
2.5 |
GO:0051182 |
coenzyme transport(GO:0051182) |
| 0.8 |
5.0 |
GO:0035507 |
regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
| 0.8 |
0.8 |
GO:1901668 |
regulation of superoxide dismutase activity(GO:1901668) |
| 0.8 |
3.3 |
GO:0071475 |
cellular hyperosmotic salinity response(GO:0071475) |
| 0.8 |
11.6 |
GO:0071378 |
growth hormone receptor signaling pathway(GO:0060396) cellular response to growth hormone stimulus(GO:0071378) |
| 0.8 |
2.5 |
GO:0060158 |
phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
| 0.8 |
0.8 |
GO:2001187 |
positive regulation of CD8-positive, alpha-beta T cell activation(GO:2001187) |
| 0.8 |
2.5 |
GO:0000973 |
posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000973) |
| 0.8 |
8.2 |
GO:1902083 |
negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) |
| 0.8 |
8.2 |
GO:0098532 |
histone H3-K27 trimethylation(GO:0098532) |
| 0.8 |
5.7 |
GO:0060575 |
intestinal epithelial cell differentiation(GO:0060575) |
| 0.8 |
4.1 |
GO:0010968 |
regulation of microtubule nucleation(GO:0010968) |
| 0.8 |
1.6 |
GO:0038026 |
reelin-mediated signaling pathway(GO:0038026) |
| 0.8 |
1.6 |
GO:0089700 |
protein kinase D signaling(GO:0089700) |
| 0.8 |
3.2 |
GO:0009405 |
pathogenesis(GO:0009405) |
| 0.8 |
5.7 |
GO:0014051 |
gamma-aminobutyric acid secretion(GO:0014051) |
| 0.8 |
1.6 |
GO:1902263 |
apoptotic process involved in embryonic digit morphogenesis(GO:1902263) |
| 0.8 |
2.4 |
GO:0046880 |
regulation of follicle-stimulating hormone secretion(GO:0046880) follicle-stimulating hormone secretion(GO:0046884) |
| 0.8 |
2.4 |
GO:0071873 |
response to norepinephrine(GO:0071873) |
| 0.8 |
1.6 |
GO:0046462 |
monoacylglycerol metabolic process(GO:0046462) |
| 0.8 |
0.8 |
GO:0046477 |
glycosylceramide catabolic process(GO:0046477) |
| 0.8 |
1.6 |
GO:0002155 |
regulation of thyroid hormone mediated signaling pathway(GO:0002155) |
| 0.8 |
3.2 |
GO:0002036 |
regulation of L-glutamate transport(GO:0002036) |
| 0.8 |
7.2 |
GO:0071420 |
cellular response to histamine(GO:0071420) |
| 0.8 |
2.4 |
GO:0010499 |
proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
| 0.8 |
1.6 |
GO:1900126 |
negative regulation of hyaluronan biosynthetic process(GO:1900126) |
| 0.8 |
0.8 |
GO:0006478 |
peptidyl-tyrosine sulfation(GO:0006478) |
| 0.8 |
2.4 |
GO:0002035 |
brain renin-angiotensin system(GO:0002035) |
| 0.8 |
3.1 |
GO:0021914 |
negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
| 0.8 |
5.5 |
GO:0007296 |
vitellogenesis(GO:0007296) |
| 0.8 |
1.6 |
GO:1904529 |
regulation of actin filament binding(GO:1904529) regulation of actin binding(GO:1904616) |
| 0.8 |
0.8 |
GO:0006929 |
substrate-dependent cell migration(GO:0006929) |
| 0.8 |
3.9 |
GO:0071699 |
olfactory placode formation(GO:0030910) olfactory placode development(GO:0071698) olfactory placode morphogenesis(GO:0071699) |
| 0.8 |
0.8 |
GO:0033239 |
negative regulation of cellular amine metabolic process(GO:0033239) |
| 0.8 |
1.6 |
GO:0003406 |
retinal pigment epithelium development(GO:0003406) |
| 0.8 |
2.3 |
GO:0070278 |
extracellular matrix constituent secretion(GO:0070278) |
| 0.8 |
3.9 |
GO:0042699 |
follicle-stimulating hormone signaling pathway(GO:0042699) |
| 0.8 |
2.3 |
GO:0021546 |
rhombomere development(GO:0021546) |
| 0.8 |
1.5 |
GO:0014010 |
Schwann cell proliferation(GO:0014010) |
| 0.8 |
1.5 |
GO:0035989 |
tendon development(GO:0035989) |
| 0.8 |
6.1 |
GO:0032020 |
ISG15-protein conjugation(GO:0032020) |
| 0.8 |
3.1 |
GO:0006710 |
androgen catabolic process(GO:0006710) |
| 0.8 |
2.3 |
GO:1902525 |
regulation of protein monoubiquitination(GO:1902525) |
| 0.8 |
3.0 |
GO:0032411 |
positive regulation of transporter activity(GO:0032411) |
| 0.8 |
1.5 |
GO:0038180 |
nerve growth factor signaling pathway(GO:0038180) |
| 0.8 |
6.0 |
GO:0071318 |
cellular response to ATP(GO:0071318) |
| 0.8 |
2.3 |
GO:1905051 |
regulation of base-excision repair(GO:1905051) positive regulation of base-excision repair(GO:1905053) |
| 0.8 |
0.8 |
GO:0060017 |
parathyroid gland development(GO:0060017) |
| 0.7 |
2.2 |
GO:0070086 |
ubiquitin-dependent endocytosis(GO:0070086) |
| 0.7 |
11.9 |
GO:2000311 |
regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
| 0.7 |
4.5 |
GO:0006290 |
pyrimidine dimer repair(GO:0006290) |
| 0.7 |
2.2 |
GO:0021998 |
neural plate mediolateral regionalization(GO:0021998) mesoderm structural organization(GO:0048338) paraxial mesoderm structural organization(GO:0048352) positive regulation of cardiac ventricle development(GO:1904414) |
| 0.7 |
0.7 |
GO:0021882 |
regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment(GO:0021882) commitment of multipotent stem cells to neuronal lineage in forebrain(GO:0021898) |
| 0.7 |
2.2 |
GO:0071579 |
regulation of zinc ion transport(GO:0071579) |
| 0.7 |
10.3 |
GO:0006895 |
Golgi to endosome transport(GO:0006895) |
| 0.7 |
0.7 |
GO:0044034 |
negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
| 0.7 |
5.8 |
GO:0048934 |
peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
| 0.7 |
10.1 |
GO:0032957 |
inositol trisphosphate metabolic process(GO:0032957) |
| 0.7 |
2.9 |
GO:0051386 |
regulation of neurotrophin TRK receptor signaling pathway(GO:0051386) |
| 0.7 |
12.2 |
GO:0015701 |
bicarbonate transport(GO:0015701) |
| 0.7 |
0.7 |
GO:0045014 |
carbon catabolite repression of transcription(GO:0045013) negative regulation of transcription by glucose(GO:0045014) |
| 0.7 |
0.7 |
GO:2000650 |
negative regulation of sodium ion transmembrane transport(GO:1902306) negative regulation of sodium ion transmembrane transporter activity(GO:2000650) |
| 0.7 |
3.5 |
GO:0071285 |
cellular response to lithium ion(GO:0071285) |
| 0.7 |
6.3 |
GO:0043011 |
myeloid dendritic cell differentiation(GO:0043011) |
| 0.7 |
2.1 |
GO:0035928 |
rRNA import into mitochondrion(GO:0035928) |
| 0.7 |
2.8 |
GO:0034315 |
regulation of Arp2/3 complex-mediated actin nucleation(GO:0034315) |
| 0.7 |
0.7 |
GO:1901165 |
positive regulation of trophoblast cell migration(GO:1901165) |
| 0.7 |
2.8 |
GO:0006049 |
UDP-N-acetylglucosamine catabolic process(GO:0006049) |
| 0.7 |
2.1 |
GO:0051342 |
regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051342) negative regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051344) |
| 0.7 |
5.5 |
GO:0048680 |
positive regulation of axon regeneration(GO:0048680) positive regulation of neuron projection regeneration(GO:0070572) |
| 0.7 |
1.4 |
GO:1903774 |
positive regulation of viral budding via host ESCRT complex(GO:1903774) |
| 0.7 |
1.4 |
GO:0033634 |
positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
| 0.7 |
2.7 |
GO:0019355 |
nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process(GO:0034627) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
| 0.7 |
21.9 |
GO:0032456 |
endocytic recycling(GO:0032456) |
| 0.7 |
2.7 |
GO:0072365 |
regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter(GO:0072365) |
| 0.7 |
6.1 |
GO:0070072 |
vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
| 0.7 |
9.5 |
GO:0032967 |
positive regulation of collagen biosynthetic process(GO:0032967) |
| 0.7 |
2.7 |
GO:2000809 |
neuroligin clustering involved in postsynaptic membrane assembly(GO:0097118) positive regulation of synaptic vesicle clustering(GO:2000809) |
| 0.7 |
6.7 |
GO:0042572 |
retinol metabolic process(GO:0042572) |
| 0.7 |
2.0 |
GO:1903608 |
protein localization to cytoplasmic stress granule(GO:1903608) |
| 0.7 |
2.0 |
GO:0035864 |
response to potassium ion(GO:0035864) cellular response to potassium ion(GO:0035865) |
| 0.7 |
8.0 |
GO:0033234 |
negative regulation of protein sumoylation(GO:0033234) |
| 0.7 |
15.4 |
GO:0007520 |
myoblast fusion(GO:0007520) |
| 0.7 |
0.7 |
GO:0070094 |
positive regulation of glucagon secretion(GO:0070094) |
| 0.7 |
2.0 |
GO:2000620 |
positive regulation of histone H4-K16 acetylation(GO:2000620) |
| 0.7 |
0.7 |
GO:1902774 |
late endosome to lysosome transport(GO:1902774) |
| 0.7 |
2.0 |
GO:2000169 |
regulation of peptidyl-cysteine S-nitrosylation(GO:2000169) |
| 0.7 |
3.3 |
GO:0097113 |
AMPA glutamate receptor clustering(GO:0097113) glutamate receptor clustering(GO:0097688) |
| 0.7 |
1.3 |
GO:0060221 |
retinal rod cell differentiation(GO:0060221) |
| 0.7 |
4.6 |
GO:1900086 |
positive regulation of peptidyl-tyrosine autophosphorylation(GO:1900086) |
| 0.7 |
3.9 |
GO:0042940 |
D-amino acid transport(GO:0042940) |
| 0.7 |
2.6 |
GO:0038128 |
ERBB2 signaling pathway(GO:0038128) |
| 0.7 |
1.3 |
GO:0031394 |
positive regulation of prostaglandin biosynthetic process(GO:0031394) positive regulation of unsaturated fatty acid biosynthetic process(GO:2001280) |
| 0.7 |
3.3 |
GO:1904781 |
positive regulation of protein localization to centrosome(GO:1904781) |
| 0.7 |
3.3 |
GO:0051534 |
negative regulation of NFAT protein import into nucleus(GO:0051534) |
| 0.7 |
0.7 |
GO:0002692 |
negative regulation of cellular extravasation(GO:0002692) |
| 0.7 |
5.9 |
GO:0070932 |
histone H3 deacetylation(GO:0070932) |
| 0.7 |
3.3 |
GO:0050861 |
positive regulation of B cell receptor signaling pathway(GO:0050861) |
| 0.6 |
7.8 |
GO:1904262 |
negative regulation of TORC1 signaling(GO:1904262) |
| 0.6 |
6.4 |
GO:1901621 |
negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
| 0.6 |
1.9 |
GO:0060763 |
mammary duct terminal end bud growth(GO:0060763) |
| 0.6 |
5.1 |
GO:0009181 |
purine nucleoside diphosphate catabolic process(GO:0009137) purine ribonucleoside diphosphate catabolic process(GO:0009181) |
| 0.6 |
1.9 |
GO:0070358 |
actin polymerization-dependent cell motility(GO:0070358) |
| 0.6 |
1.9 |
GO:0021894 |
cerebral cortex GABAergic interneuron development(GO:0021894) |
| 0.6 |
8.9 |
GO:0006490 |
oligosaccharide-lipid intermediate biosynthetic process(GO:0006490) |
| 0.6 |
2.5 |
GO:0099527 |
postsynapse to nucleus signaling pathway(GO:0099527) |
| 0.6 |
2.5 |
GO:0035608 |
protein deglutamylation(GO:0035608) |
| 0.6 |
5.7 |
GO:0010745 |
negative regulation of macrophage derived foam cell differentiation(GO:0010745) |
| 0.6 |
1.3 |
GO:0042373 |
vitamin K metabolic process(GO:0042373) |
| 0.6 |
4.4 |
GO:0035411 |
catenin import into nucleus(GO:0035411) |
| 0.6 |
1.2 |
GO:0071879 |
positive regulation of adrenergic receptor signaling pathway(GO:0071879) |
| 0.6 |
3.1 |
GO:0009404 |
toxin metabolic process(GO:0009404) |
| 0.6 |
2.5 |
GO:0021938 |
smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation(GO:0021938) notochord regression(GO:0060032) |
| 0.6 |
1.9 |
GO:0006072 |
glycerol-3-phosphate metabolic process(GO:0006072) |
| 0.6 |
3.1 |
GO:0019433 |
triglyceride catabolic process(GO:0019433) |
| 0.6 |
15.5 |
GO:0032011 |
ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
| 0.6 |
2.5 |
GO:0051775 |
response to redox state(GO:0051775) |
| 0.6 |
0.6 |
GO:0032911 |
negative regulation of transforming growth factor beta1 production(GO:0032911) |
| 0.6 |
2.5 |
GO:1904694 |
negative regulation of vascular smooth muscle contraction(GO:1904694) |
| 0.6 |
5.0 |
GO:0045721 |
negative regulation of gluconeogenesis(GO:0045721) |
| 0.6 |
1.8 |
GO:0030974 |
thiamine pyrophosphate transport(GO:0030974) |
| 0.6 |
2.5 |
GO:0042985 |
negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
| 0.6 |
3.1 |
GO:0010025 |
wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
| 0.6 |
3.0 |
GO:0071894 |
histone H2B conserved C-terminal lysine ubiquitination(GO:0071894) |
| 0.6 |
2.4 |
GO:0006558 |
L-phenylalanine metabolic process(GO:0006558) erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process(GO:1902221) |
| 0.6 |
1.8 |
GO:0032380 |
regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
| 0.6 |
3.6 |
GO:0010820 |
positive regulation of T cell chemotaxis(GO:0010820) |
| 0.6 |
1.8 |
GO:0090315 |
negative regulation of protein targeting to membrane(GO:0090315) |
| 0.6 |
1.2 |
GO:0060857 |
establishment of glial blood-brain barrier(GO:0060857) |
| 0.6 |
1.8 |
GO:0035526 |
retrograde transport, plasma membrane to Golgi(GO:0035526) |
| 0.6 |
2.4 |
GO:0008355 |
olfactory learning(GO:0008355) |
| 0.6 |
2.4 |
GO:0045717 |
negative regulation of fatty acid biosynthetic process(GO:0045717) |
| 0.6 |
2.9 |
GO:0005513 |
detection of calcium ion(GO:0005513) |
| 0.6 |
8.1 |
GO:0022027 |
interkinetic nuclear migration(GO:0022027) |
| 0.6 |
5.8 |
GO:0046339 |
diacylglycerol metabolic process(GO:0046339) |
| 0.6 |
3.5 |
GO:0097264 |
self proteolysis(GO:0097264) |
| 0.6 |
1.7 |
GO:2001013 |
epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
| 0.6 |
2.3 |
GO:1904354 |
negative regulation of telomere capping(GO:1904354) |
| 0.6 |
1.7 |
GO:0071787 |
endoplasmic reticulum tubular network assembly(GO:0071787) |
| 0.6 |
2.3 |
GO:0006646 |
phosphatidylethanolamine biosynthetic process(GO:0006646) |
| 0.6 |
2.3 |
GO:1901678 |
iron coordination entity transport(GO:1901678) |
| 0.6 |
1.7 |
GO:1903422 |
negative regulation of synaptic vesicle recycling(GO:1903422) |
| 0.6 |
0.6 |
GO:0010040 |
response to iron(II) ion(GO:0010040) |
| 0.6 |
2.9 |
GO:0021957 |
corticospinal tract morphogenesis(GO:0021957) |
| 0.6 |
1.1 |
GO:0007182 |
common-partner SMAD protein phosphorylation(GO:0007182) |
| 0.6 |
2.9 |
GO:0015808 |
L-alanine transport(GO:0015808) |
| 0.6 |
2.8 |
GO:0035063 |
nuclear speck organization(GO:0035063) |
| 0.6 |
1.7 |
GO:0097094 |
craniofacial suture morphogenesis(GO:0097094) |
| 0.6 |
2.3 |
GO:1904451 |
regulation of hydrogen:potassium-exchanging ATPase activity(GO:1904451) positive regulation of hydrogen:potassium-exchanging ATPase activity(GO:1904453) |
| 0.6 |
2.8 |
GO:0016266 |
O-glycan processing(GO:0016266) |
| 0.6 |
2.8 |
GO:0006842 |
tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
| 0.6 |
5.5 |
GO:0033292 |
T-tubule organization(GO:0033292) |
| 0.6 |
1.7 |
GO:0036500 |
ATF6-mediated unfolded protein response(GO:0036500) |
| 0.6 |
1.7 |
GO:0048298 |
positive regulation of isotype switching to IgA isotypes(GO:0048298) |
| 0.6 |
0.6 |
GO:1901896 |
positive regulation of calcium-transporting ATPase activity(GO:1901896) |
| 0.6 |
1.7 |
GO:0071929 |
alpha-tubulin acetylation(GO:0071929) |
| 0.5 |
17.5 |
GO:0046834 |
lipid phosphorylation(GO:0046834) |
| 0.5 |
0.5 |
GO:0072720 |
response to dithiothreitol(GO:0072720) |
| 0.5 |
2.7 |
GO:0043615 |
astrocyte cell migration(GO:0043615) |
| 0.5 |
0.5 |
GO:0072338 |
creatinine metabolic process(GO:0046449) cellular lactam metabolic process(GO:0072338) |
| 0.5 |
1.6 |
GO:0016240 |
autophagosome docking(GO:0016240) |
| 0.5 |
2.2 |
GO:0033564 |
anterior/posterior axon guidance(GO:0033564) |
| 0.5 |
2.7 |
GO:0035635 |
entry of bacterium into host cell(GO:0035635) regulation of entry of bacterium into host cell(GO:2000535) |
| 0.5 |
2.7 |
GO:0042058 |
regulation of epidermal growth factor receptor signaling pathway(GO:0042058) regulation of ERBB signaling pathway(GO:1901184) |
| 0.5 |
1.1 |
GO:0006409 |
tRNA export from nucleus(GO:0006409) tRNA transport(GO:0051031) tRNA-containing ribonucleoprotein complex export from nucleus(GO:0071431) |
| 0.5 |
1.1 |
GO:0031146 |
SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
| 0.5 |
2.1 |
GO:0051725 |
protein de-ADP-ribosylation(GO:0051725) |
| 0.5 |
5.4 |
GO:0010839 |
negative regulation of keratinocyte proliferation(GO:0010839) |
| 0.5 |
7.5 |
GO:0007413 |
axonal fasciculation(GO:0007413) |
| 0.5 |
1.1 |
GO:0021506 |
anterior neuropore closure(GO:0021506) neuropore closure(GO:0021995) |
| 0.5 |
1.1 |
GO:0003376 |
sphingosine-1-phosphate signaling pathway(GO:0003376) sphingolipid mediated signaling pathway(GO:0090520) |
| 0.5 |
1.6 |
GO:0035470 |
positive regulation of vascular wound healing(GO:0035470) |
| 0.5 |
1.1 |
GO:0021965 |
spinal cord ventral commissure morphogenesis(GO:0021965) |
| 0.5 |
0.5 |
GO:0071955 |
recycling endosome to Golgi transport(GO:0071955) |
| 0.5 |
1.1 |
GO:0018199 |
peptidyl-glutamine modification(GO:0018199) |
| 0.5 |
1.1 |
GO:0006116 |
NADH oxidation(GO:0006116) |
| 0.5 |
3.2 |
GO:0097475 |
motor neuron migration(GO:0097475) |
| 0.5 |
1.6 |
GO:2000016 |
negative regulation of determination of dorsal identity(GO:2000016) |
| 0.5 |
1.6 |
GO:0030828 |
positive regulation of cGMP biosynthetic process(GO:0030828) |
| 0.5 |
1.6 |
GO:0071544 |
diphosphoinositol polyphosphate catabolic process(GO:0071544) |
| 0.5 |
1.5 |
GO:0010730 |
negative regulation of hydrogen peroxide metabolic process(GO:0010727) negative regulation of hydrogen peroxide biosynthetic process(GO:0010730) |
| 0.5 |
1.0 |
GO:2000409 |
positive regulation of T cell extravasation(GO:2000409) |
| 0.5 |
2.1 |
GO:0048703 |
embryonic viscerocranium morphogenesis(GO:0048703) |
| 0.5 |
1.5 |
GO:0061743 |
motor learning(GO:0061743) |
| 0.5 |
2.6 |
GO:0031034 |
myosin filament assembly(GO:0031034) |
| 0.5 |
2.0 |
GO:0042420 |
dopamine catabolic process(GO:0042420) |
| 0.5 |
1.5 |
GO:0000301 |
retrograde transport, vesicle recycling within Golgi(GO:0000301) |
| 0.5 |
28.5 |
GO:0031338 |
regulation of vesicle fusion(GO:0031338) |
| 0.5 |
1.0 |
GO:0045006 |
DNA deamination(GO:0045006) |
| 0.5 |
1.5 |
GO:1905169 |
protein localization to phagocytic vesicle(GO:1905161) regulation of protein localization to phagocytic vesicle(GO:1905169) positive regulation of protein localization to phagocytic vesicle(GO:1905171) |
| 0.5 |
3.5 |
GO:0035826 |
rubidium ion transport(GO:0035826) |
| 0.5 |
3.0 |
GO:0019695 |
choline metabolic process(GO:0019695) |
| 0.5 |
2.5 |
GO:0043353 |
enucleate erythrocyte differentiation(GO:0043353) |
| 0.5 |
2.5 |
GO:0051096 |
regulation of helicase activity(GO:0051095) positive regulation of helicase activity(GO:0051096) |
| 0.5 |
2.0 |
GO:0003365 |
establishment of cell polarity involved in ameboidal cell migration(GO:0003365) |
| 0.5 |
1.5 |
GO:0014912 |
negative regulation of smooth muscle cell migration(GO:0014912) |
| 0.5 |
1.5 |
GO:0002182 |
cytoplasmic translational elongation(GO:0002182) thermoception(GO:0050955) regulation of cytoplasmic translational elongation(GO:1900247) negative regulation of cytoplasmic translational elongation(GO:1900248) |
| 0.5 |
1.5 |
GO:0016242 |
negative regulation of macroautophagy(GO:0016242) |
| 0.5 |
1.0 |
GO:0035694 |
mitochondrial protein catabolic process(GO:0035694) |
| 0.5 |
2.9 |
GO:0045898 |
regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045898) |
| 0.5 |
31.3 |
GO:0007156 |
homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
| 0.5 |
4.4 |
GO:0006013 |
mannose metabolic process(GO:0006013) |
| 0.5 |
3.4 |
GO:0006686 |
sphingomyelin biosynthetic process(GO:0006686) |
| 0.5 |
1.5 |
GO:0046341 |
CDP-diacylglycerol metabolic process(GO:0046341) |
| 0.5 |
2.9 |
GO:0015015 |
heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
| 0.5 |
0.5 |
GO:0036092 |
phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
| 0.5 |
0.5 |
GO:0090298 |
negative regulation of mitochondrial DNA replication(GO:0090298) negative regulation of mitochondrial DNA metabolic process(GO:1901859) |
| 0.5 |
2.9 |
GO:1901844 |
regulation of cell communication by electrical coupling involved in cardiac conduction(GO:1901844) |
| 0.5 |
1.0 |
GO:0060355 |
positive regulation of cell adhesion molecule production(GO:0060355) |
| 0.5 |
1.4 |
GO:0042560 |
10-formyltetrahydrofolate catabolic process(GO:0009258) folic acid-containing compound catabolic process(GO:0009397) pteridine-containing compound catabolic process(GO:0042560) |
| 0.5 |
1.4 |
GO:0044208 |
'de novo' AMP biosynthetic process(GO:0044208) |
| 0.5 |
2.4 |
GO:2000253 |
positive regulation of feeding behavior(GO:2000253) |
| 0.5 |
1.9 |
GO:0070829 |
heterochromatin maintenance(GO:0070829) |
| 0.5 |
3.3 |
GO:0090074 |
negative regulation of protein homodimerization activity(GO:0090074) |
| 0.5 |
2.8 |
GO:0040015 |
negative regulation of multicellular organism growth(GO:0040015) |
| 0.5 |
1.9 |
GO:0034427 |
nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5'(GO:0034427) |
| 0.5 |
4.7 |
GO:0006620 |
posttranslational protein targeting to membrane(GO:0006620) |
| 0.5 |
3.3 |
GO:0071455 |
cellular response to hyperoxia(GO:0071455) |
| 0.5 |
1.9 |
GO:0042138 |
meiotic DNA double-strand break formation(GO:0042138) |
| 0.5 |
0.9 |
GO:0090331 |
negative regulation of platelet aggregation(GO:0090331) |
| 0.5 |
2.3 |
GO:0048520 |
positive regulation of behavior(GO:0048520) |
| 0.5 |
2.8 |
GO:0030578 |
PML body organization(GO:0030578) |
| 0.5 |
0.9 |
GO:0036394 |
amylase secretion(GO:0036394) |
| 0.5 |
1.4 |
GO:0042196 |
dichloromethane metabolic process(GO:0018900) chlorinated hydrocarbon metabolic process(GO:0042196) halogenated hydrocarbon metabolic process(GO:0042197) |
| 0.5 |
2.8 |
GO:0071630 |
nucleus-associated proteasomal ubiquitin-dependent protein catabolic process(GO:0071630) |
| 0.5 |
1.8 |
GO:0006616 |
SRP-dependent cotranslational protein targeting to membrane, translocation(GO:0006616) |
| 0.5 |
1.8 |
GO:0055071 |
cellular manganese ion homeostasis(GO:0030026) Golgi calcium ion homeostasis(GO:0032468) manganese ion homeostasis(GO:0055071) |
| 0.5 |
0.5 |
GO:0034144 |
negative regulation of receptor biosynthetic process(GO:0010871) negative regulation of toll-like receptor 4 signaling pathway(GO:0034144) |
| 0.5 |
2.3 |
GO:0097368 |
establishment of Sertoli cell barrier(GO:0097368) |
| 0.5 |
0.9 |
GO:0021960 |
anterior commissure morphogenesis(GO:0021960) |
| 0.5 |
1.8 |
GO:0046007 |
negative regulation of activated T cell proliferation(GO:0046007) |
| 0.5 |
0.9 |
GO:0043619 |
regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0043619) |
| 0.5 |
1.8 |
GO:0006668 |
sphinganine-1-phosphate metabolic process(GO:0006668) |
| 0.4 |
1.3 |
GO:1903538 |
meiotic cell cycle process involved in oocyte maturation(GO:1903537) regulation of meiotic cell cycle process involved in oocyte maturation(GO:1903538) |
| 0.4 |
0.4 |
GO:1902669 |
positive regulation of axon guidance(GO:1902669) |
| 0.4 |
3.6 |
GO:0071569 |
protein ufmylation(GO:0071569) |
| 0.4 |
2.7 |
GO:0090383 |
phagosome acidification(GO:0090383) |
| 0.4 |
0.4 |
GO:0097211 |
response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
| 0.4 |
1.3 |
GO:0048227 |
plasma membrane to endosome transport(GO:0048227) |
| 0.4 |
0.9 |
GO:0090370 |
negative regulation of cholesterol efflux(GO:0090370) |
| 0.4 |
0.4 |
GO:0070827 |
chromatin maintenance(GO:0070827) |
| 0.4 |
1.7 |
GO:1903031 |
regulation of microtubule plus-end binding(GO:1903031) positive regulation of microtubule plus-end binding(GO:1903033) |
| 0.4 |
2.2 |
GO:0070314 |
G1 to G0 transition(GO:0070314) |
| 0.4 |
0.9 |
GO:0033484 |
nitric oxide homeostasis(GO:0033484) |
| 0.4 |
2.6 |
GO:2000310 |
regulation of N-methyl-D-aspartate selective glutamate receptor activity(GO:2000310) |
| 0.4 |
1.3 |
GO:0090038 |
negative regulation of protein kinase C signaling(GO:0090038) |
| 0.4 |
1.7 |
GO:0006003 |
fructose 2,6-bisphosphate metabolic process(GO:0006003) |
| 0.4 |
2.1 |
GO:0043416 |
regulation of skeletal muscle tissue regeneration(GO:0043416) |
| 0.4 |
2.6 |
GO:1900246 |
positive regulation of RIG-I signaling pathway(GO:1900246) |
| 0.4 |
3.0 |
GO:0016139 |
glycoside catabolic process(GO:0016139) |
| 0.4 |
1.7 |
GO:0097039 |
protein linear polyubiquitination(GO:0097039) |
| 0.4 |
0.8 |
GO:0001955 |
blood vessel maturation(GO:0001955) |
| 0.4 |
2.1 |
GO:0034472 |
snRNA 3'-end processing(GO:0034472) |
| 0.4 |
0.8 |
GO:0097051 |
establishment of protein localization to endoplasmic reticulum membrane(GO:0097051) |
| 0.4 |
7.6 |
GO:0046033 |
AMP metabolic process(GO:0046033) |
| 0.4 |
2.9 |
GO:0032287 |
peripheral nervous system myelin maintenance(GO:0032287) |
| 0.4 |
3.8 |
GO:0070995 |
NADPH oxidation(GO:0070995) |
| 0.4 |
18.3 |
GO:0009311 |
oligosaccharide metabolic process(GO:0009311) |
| 0.4 |
0.4 |
GO:0098705 |
plasma membrane copper ion transport(GO:0015679) copper ion import across plasma membrane(GO:0098705) copper ion import into cell(GO:1902861) |
| 0.4 |
1.2 |
GO:0052646 |
alditol phosphate metabolic process(GO:0052646) |
| 0.4 |
1.2 |
GO:0006592 |
ornithine biosynthetic process(GO:0006592) |
| 0.4 |
0.8 |
GO:0051593 |
response to folic acid(GO:0051593) |
| 0.4 |
2.1 |
GO:0035188 |
blastocyst hatching(GO:0001835) hatching(GO:0035188) organism emergence from protective structure(GO:0071684) |
| 0.4 |
0.8 |
GO:0006507 |
GPI anchor release(GO:0006507) |
| 0.4 |
8.9 |
GO:0032007 |
negative regulation of TOR signaling(GO:0032007) |
| 0.4 |
0.4 |
GO:0072425 |
signal transduction involved in G2 DNA damage checkpoint(GO:0072425) signal transduction involved in mitotic G2 DNA damage checkpoint(GO:0072434) |
| 0.4 |
1.6 |
GO:0090219 |
negative regulation of lipid kinase activity(GO:0090219) |
| 0.4 |
0.4 |
GO:0007041 |
lysosomal transport(GO:0007041) |
| 0.4 |
0.8 |
GO:1900034 |
regulation of cellular response to heat(GO:1900034) |
| 0.4 |
7.2 |
GO:0070528 |
protein kinase C signaling(GO:0070528) |
| 0.4 |
0.4 |
GO:0030813 |
positive regulation of nucleotide catabolic process(GO:0030813) positive regulation of glycolytic process(GO:0045821) positive regulation of cofactor metabolic process(GO:0051194) positive regulation of coenzyme metabolic process(GO:0051197) |
| 0.4 |
0.4 |
GO:0070070 |
proton-transporting V-type ATPase complex assembly(GO:0070070) |
| 0.4 |
1.6 |
GO:1904953 |
Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation(GO:1904953) |
| 0.4 |
7.5 |
GO:0090140 |
regulation of mitochondrial fission(GO:0090140) |
| 0.4 |
2.4 |
GO:0006741 |
NADP biosynthetic process(GO:0006741) |
| 0.4 |
7.1 |
GO:0015693 |
magnesium ion transport(GO:0015693) |
| 0.4 |
0.8 |
GO:0002638 |
negative regulation of immunoglobulin production(GO:0002638) |
| 0.4 |
1.2 |
GO:0070602 |
regulation of centromeric sister chromatid cohesion(GO:0070602) |
| 0.4 |
3.5 |
GO:0018095 |
protein polyglutamylation(GO:0018095) |
| 0.4 |
2.3 |
GO:0034983 |
peptidyl-lysine deacetylation(GO:0034983) |
| 0.4 |
1.2 |
GO:0005981 |
regulation of glycogen catabolic process(GO:0005981) |
| 0.4 |
2.3 |
GO:0034638 |
phosphatidylcholine catabolic process(GO:0034638) |
| 0.4 |
1.2 |
GO:0021691 |
cerebellar Purkinje cell layer maturation(GO:0021691) |
| 0.4 |
0.4 |
GO:0071504 |
response to heparin(GO:0071503) cellular response to heparin(GO:0071504) |
| 0.4 |
1.9 |
GO:0014886 |
transition between slow and fast fiber(GO:0014886) |
| 0.4 |
2.7 |
GO:0035994 |
response to muscle stretch(GO:0035994) |
| 0.4 |
0.4 |
GO:0065001 |
specification of axis polarity(GO:0065001) |
| 0.4 |
9.2 |
GO:0071108 |
protein K48-linked deubiquitination(GO:0071108) |
| 0.4 |
5.7 |
GO:0006903 |
vesicle targeting(GO:0006903) |
| 0.4 |
0.4 |
GO:0019732 |
antifungal humoral response(GO:0019732) antifungal innate immune response(GO:0061760) |
| 0.4 |
1.1 |
GO:1902915 |
negative regulation of protein K63-linked ubiquitination(GO:1900045) negative regulation of protein polyubiquitination(GO:1902915) |
| 0.4 |
3.0 |
GO:0001941 |
postsynaptic membrane organization(GO:0001941) |
| 0.4 |
1.1 |
GO:0060708 |
spongiotrophoblast differentiation(GO:0060708) |
| 0.4 |
9.8 |
GO:0043113 |
receptor clustering(GO:0043113) |
| 0.4 |
1.9 |
GO:0007202 |
activation of phospholipase C activity(GO:0007202) |
| 0.4 |
0.4 |
GO:1902445 |
regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
| 0.4 |
0.4 |
GO:2000273 |
positive regulation of receptor activity(GO:2000273) |
| 0.4 |
0.7 |
GO:0002361 |
CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0002361) |
| 0.4 |
4.8 |
GO:0010738 |
regulation of protein kinase A signaling(GO:0010738) |
| 0.4 |
10.0 |
GO:0016578 |
histone deubiquitination(GO:0016578) |
| 0.4 |
1.5 |
GO:0031953 |
negative regulation of protein autophosphorylation(GO:0031953) |
| 0.4 |
0.4 |
GO:0090289 |
regulation of osteoclast proliferation(GO:0090289) |
| 0.4 |
4.0 |
GO:0045351 |
type I interferon biosynthetic process(GO:0045351) |
| 0.4 |
9.4 |
GO:0001881 |
receptor recycling(GO:0001881) |
| 0.4 |
1.1 |
GO:0002946 |
tRNA C5-cytosine methylation(GO:0002946) |
| 0.4 |
0.4 |
GO:0061299 |
retina vasculature morphogenesis in camera-type eye(GO:0061299) |
| 0.4 |
8.6 |
GO:0008333 |
endosome to lysosome transport(GO:0008333) |
| 0.4 |
1.4 |
GO:0042796 |
snRNA transcription from RNA polymerase III promoter(GO:0042796) |
| 0.4 |
2.8 |
GO:0034498 |
early endosome to Golgi transport(GO:0034498) |
| 0.4 |
2.5 |
GO:2000291 |
regulation of myoblast proliferation(GO:2000291) |
| 0.4 |
3.9 |
GO:0090503 |
RNA phosphodiester bond hydrolysis, exonucleolytic(GO:0090503) |
| 0.4 |
3.2 |
GO:0007168 |
receptor guanylyl cyclase signaling pathway(GO:0007168) |
| 0.4 |
3.5 |
GO:0007220 |
Notch receptor processing(GO:0007220) |
| 0.4 |
2.5 |
GO:0006622 |
protein targeting to lysosome(GO:0006622) |
| 0.4 |
1.1 |
GO:1903265 |
positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
| 0.4 |
2.5 |
GO:2000786 |
positive regulation of autophagosome assembly(GO:2000786) |
| 0.4 |
2.8 |
GO:0032292 |
myelination in peripheral nervous system(GO:0022011) peripheral nervous system axon ensheathment(GO:0032292) |
| 0.4 |
1.8 |
GO:1990440 |
positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990440) |
| 0.4 |
7.4 |
GO:0030970 |
retrograde protein transport, ER to cytosol(GO:0030970) |
| 0.4 |
2.1 |
GO:0006102 |
isocitrate metabolic process(GO:0006102) |
| 0.3 |
0.3 |
GO:0006702 |
androgen biosynthetic process(GO:0006702) |
| 0.3 |
2.1 |
GO:0048312 |
intracellular distribution of mitochondria(GO:0048312) |
| 0.3 |
0.3 |
GO:0035434 |
copper ion transmembrane transport(GO:0035434) |
| 0.3 |
0.3 |
GO:2000670 |
positive regulation of dendritic cell apoptotic process(GO:2000670) |
| 0.3 |
0.7 |
GO:0048262 |
determination of dorsal/ventral asymmetry(GO:0048262) determination of dorsal identity(GO:0048263) |
| 0.3 |
3.1 |
GO:0009950 |
dorsal/ventral axis specification(GO:0009950) |
| 0.3 |
2.7 |
GO:0071816 |
tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
| 0.3 |
1.7 |
GO:1902895 |
positive regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902895) |
| 0.3 |
3.1 |
GO:0033169 |
histone H3-K9 demethylation(GO:0033169) |
| 0.3 |
1.0 |
GO:0036438 |
maintenance of lens transparency(GO:0036438) |
| 0.3 |
1.7 |
GO:0006384 |
transcription initiation from RNA polymerase III promoter(GO:0006384) |
| 0.3 |
2.4 |
GO:0018344 |
protein geranylgeranylation(GO:0018344) |
| 0.3 |
1.3 |
GO:2000651 |
positive regulation of sodium ion transmembrane transporter activity(GO:2000651) |
| 0.3 |
2.0 |
GO:0030579 |
ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
| 0.3 |
1.3 |
GO:0010713 |
negative regulation of collagen metabolic process(GO:0010713) negative regulation of collagen biosynthetic process(GO:0032966) |
| 0.3 |
7.7 |
GO:0015991 |
ATP hydrolysis coupled proton transport(GO:0015991) ATP hydrolysis coupled transmembrane transport(GO:0090662) |
| 0.3 |
1.3 |
GO:0019276 |
UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
| 0.3 |
4.0 |
GO:0048240 |
sperm capacitation(GO:0048240) |
| 0.3 |
5.7 |
GO:0061029 |
eyelid development in camera-type eye(GO:0061029) |
| 0.3 |
1.3 |
GO:0090273 |
regulation of somatostatin secretion(GO:0090273) |
| 0.3 |
1.3 |
GO:0010832 |
negative regulation of myotube differentiation(GO:0010832) |
| 0.3 |
1.0 |
GO:1904491 |
protein localization to ciliary transition zone(GO:1904491) |
| 0.3 |
1.0 |
GO:0055091 |
phospholipid homeostasis(GO:0055091) |
| 0.3 |
0.3 |
GO:0080144 |
amino acid homeostasis(GO:0080144) |
| 0.3 |
3.0 |
GO:0071578 |
zinc II ion transmembrane import(GO:0071578) |
| 0.3 |
0.3 |
GO:1900242 |
regulation of synaptic vesicle endocytosis(GO:1900242) |
| 0.3 |
0.7 |
GO:0061343 |
cell adhesion involved in heart morphogenesis(GO:0061343) |
| 0.3 |
1.3 |
GO:0045075 |
interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
| 0.3 |
3.6 |
GO:1990403 |
embryonic brain development(GO:1990403) |
| 0.3 |
0.6 |
GO:0021812 |
neuronal-glial interaction involved in cerebral cortex radial glia guided migration(GO:0021812) |
| 0.3 |
2.9 |
GO:0006002 |
fructose 6-phosphate metabolic process(GO:0006002) |
| 0.3 |
1.3 |
GO:0072531 |
pyrimidine-containing compound transmembrane transport(GO:0072531) |
| 0.3 |
0.6 |
GO:0060509 |
Type I pneumocyte differentiation(GO:0060509) |
| 0.3 |
1.0 |
GO:1903626 |
positive regulation of DNA catabolic process(GO:1903626) |
| 0.3 |
1.0 |
GO:0006624 |
vacuolar protein processing(GO:0006624) |
| 0.3 |
1.9 |
GO:0051958 |
methotrexate transport(GO:0051958) reduced folate transmembrane transport(GO:0098838) |
| 0.3 |
1.0 |
GO:0031860 |
telomeric 3' overhang formation(GO:0031860) |
| 0.3 |
1.9 |
GO:0051790 |
short-chain fatty acid biosynthetic process(GO:0051790) |
| 0.3 |
1.6 |
GO:0098967 |
exocytic insertion of neurotransmitter receptor to plasma membrane(GO:0098881) exocytic insertion of neurotransmitter receptor to postsynaptic membrane(GO:0098967) |
| 0.3 |
1.3 |
GO:0006982 |
response to lipid hydroperoxide(GO:0006982) cellular response to lipid hydroperoxide(GO:0071449) |
| 0.3 |
2.2 |
GO:0080182 |
histone H3-K4 trimethylation(GO:0080182) |
| 0.3 |
1.0 |
GO:0034035 |
sulfate assimilation(GO:0000103) purine ribonucleoside bisphosphate metabolic process(GO:0034035) 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
| 0.3 |
1.6 |
GO:0016557 |
peroxisome membrane biogenesis(GO:0016557) |
| 0.3 |
3.5 |
GO:0007274 |
neuromuscular synaptic transmission(GO:0007274) |
| 0.3 |
0.6 |
GO:0045026 |
plasma membrane fusion(GO:0045026) |
| 0.3 |
0.6 |
GO:0071404 |
cellular response to lipoprotein particle stimulus(GO:0071402) cellular response to low-density lipoprotein particle stimulus(GO:0071404) |
| 0.3 |
1.2 |
GO:1901660 |
calcium ion export(GO:1901660) |
| 0.3 |
1.2 |
GO:1990573 |
potassium ion import across plasma membrane(GO:1990573) |
| 0.3 |
5.0 |
GO:0002115 |
store-operated calcium entry(GO:0002115) |
| 0.3 |
1.6 |
GO:0034720 |
histone H3-K4 demethylation(GO:0034720) |
| 0.3 |
0.9 |
GO:0061386 |
closure of optic fissure(GO:0061386) |
| 0.3 |
0.6 |
GO:1902412 |
regulation of mitotic cytokinesis(GO:1902412) |
| 0.3 |
2.5 |
GO:0071467 |
cellular response to pH(GO:0071467) |
| 0.3 |
2.8 |
GO:0042182 |
ketone catabolic process(GO:0042182) |
| 0.3 |
1.8 |
GO:0051045 |
negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
| 0.3 |
0.6 |
GO:0070098 |
chemokine-mediated signaling pathway(GO:0070098) |
| 0.3 |
1.2 |
GO:0051491 |
positive regulation of filopodium assembly(GO:0051491) |
| 0.3 |
0.9 |
GO:0019085 |
early viral transcription(GO:0019085) |
| 0.3 |
0.3 |
GO:0032429 |
regulation of phospholipase A2 activity(GO:0032429) |
| 0.3 |
5.7 |
GO:0030204 |
chondroitin sulfate metabolic process(GO:0030204) |
| 0.3 |
0.3 |
GO:0060003 |
copper ion export(GO:0060003) |
| 0.3 |
2.1 |
GO:0042769 |
DNA damage response, detection of DNA damage(GO:0042769) |
| 0.3 |
0.9 |
GO:0035973 |
aggrephagy(GO:0035973) |
| 0.3 |
0.3 |
GO:0060971 |
embryonic heart tube left/right pattern formation(GO:0060971) |
| 0.3 |
3.6 |
GO:0043982 |
histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
| 0.3 |
1.5 |
GO:0036337 |
Fas signaling pathway(GO:0036337) |
| 0.3 |
3.6 |
GO:0035881 |
amacrine cell differentiation(GO:0035881) |
| 0.3 |
0.3 |
GO:0002678 |
positive regulation of chronic inflammatory response(GO:0002678) |
| 0.3 |
0.9 |
GO:0072382 |
minus-end-directed vesicle transport along microtubule(GO:0072382) |
| 0.3 |
1.2 |
GO:0090077 |
macrophage derived foam cell differentiation(GO:0010742) foam cell differentiation(GO:0090077) |
| 0.3 |
0.6 |
GO:2001015 |
negative regulation of skeletal muscle cell differentiation(GO:2001015) |
| 0.3 |
4.7 |
GO:0009081 |
branched-chain amino acid metabolic process(GO:0009081) |
| 0.3 |
3.5 |
GO:0044144 |
regulation of growth of symbiont in host(GO:0044126) modulation of growth of symbiont involved in interaction with host(GO:0044144) |
| 0.3 |
0.6 |
GO:0042045 |
epithelial fluid transport(GO:0042045) |
| 0.3 |
0.6 |
GO:0061042 |
vascular wound healing(GO:0061042) |
| 0.3 |
0.6 |
GO:0097084 |
vascular smooth muscle cell development(GO:0097084) |
| 0.3 |
0.9 |
GO:1901052 |
sarcosine metabolic process(GO:1901052) sarcosine catabolic process(GO:1901053) |
| 0.3 |
0.3 |
GO:2000830 |
vacuolar phosphate transport(GO:0007037) vitamin D3 metabolic process(GO:0070640) positive regulation of parathyroid hormone secretion(GO:2000830) |
| 0.3 |
0.6 |
GO:0010726 |
positive regulation of hydrogen peroxide metabolic process(GO:0010726) |
| 0.3 |
1.1 |
GO:0009212 |
dTTP biosynthetic process(GO:0006235) pyrimidine deoxyribonucleoside triphosphate biosynthetic process(GO:0009212) dTTP metabolic process(GO:0046075) |
| 0.3 |
1.7 |
GO:0007016 |
cytoskeletal anchoring at plasma membrane(GO:0007016) |
| 0.3 |
0.3 |
GO:0018201 |
peptidyl-glycine modification(GO:0018201) |
| 0.3 |
0.6 |
GO:0001573 |
ganglioside metabolic process(GO:0001573) |
| 0.3 |
0.8 |
GO:0051004 |
regulation of lipoprotein lipase activity(GO:0051004) |
| 0.3 |
0.3 |
GO:0015864 |
pyrimidine nucleoside transport(GO:0015864) |
| 0.3 |
0.6 |
GO:0000965 |
mitochondrial RNA 3'-end processing(GO:0000965) |
| 0.3 |
0.8 |
GO:0006436 |
tryptophanyl-tRNA aminoacylation(GO:0006436) |
| 0.3 |
2.8 |
GO:0006264 |
mitochondrial DNA replication(GO:0006264) |
| 0.3 |
0.6 |
GO:1904430 |
negative regulation of t-circle formation(GO:1904430) |
| 0.3 |
2.2 |
GO:0090084 |
negative regulation of inclusion body assembly(GO:0090084) |
| 0.3 |
1.7 |
GO:0060134 |
prepulse inhibition(GO:0060134) |
| 0.3 |
0.3 |
GO:0002903 |
negative regulation of B cell apoptotic process(GO:0002903) |
| 0.3 |
2.2 |
GO:0070842 |
aggresome assembly(GO:0070842) |
| 0.3 |
1.1 |
GO:0045200 |
establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
| 0.3 |
0.8 |
GO:0070886 |
positive regulation of calcineurin-NFAT signaling cascade(GO:0070886) |
| 0.3 |
1.1 |
GO:0071442 |
regulation of histone H3-K14 acetylation(GO:0071440) positive regulation of histone H3-K14 acetylation(GO:0071442) |
| 0.3 |
0.5 |
GO:0071260 |
cellular response to mechanical stimulus(GO:0071260) |
| 0.3 |
1.4 |
GO:0031115 |
negative regulation of microtubule polymerization(GO:0031115) |
| 0.3 |
0.5 |
GO:1901419 |
regulation of vitamin D receptor signaling pathway(GO:0070562) regulation of response to alcohol(GO:1901419) |
| 0.3 |
0.5 |
GO:0010818 |
T cell chemotaxis(GO:0010818) |
| 0.3 |
1.6 |
GO:0051560 |
mitochondrial calcium ion homeostasis(GO:0051560) |
| 0.3 |
0.5 |
GO:0071372 |
cellular response to follicle-stimulating hormone stimulus(GO:0071372) |
| 0.3 |
1.6 |
GO:0072396 |
response to cell cycle checkpoint signaling(GO:0072396) response to DNA integrity checkpoint signaling(GO:0072402) response to DNA damage checkpoint signaling(GO:0072423) |
| 0.3 |
0.5 |
GO:0050703 |
interleukin-1 alpha production(GO:0032610) interleukin-1 alpha secretion(GO:0050703) |
| 0.3 |
1.1 |
GO:0015879 |
carnitine transport(GO:0015879) |
| 0.3 |
0.3 |
GO:0072008 |
glomerular mesangial cell differentiation(GO:0072008) glomerular mesangial cell development(GO:0072144) |
| 0.3 |
0.3 |
GO:1903772 |
regulation of viral budding via host ESCRT complex(GO:1903772) |
| 0.3 |
2.6 |
GO:0007175 |
negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
| 0.3 |
2.1 |
GO:1903874 |
ferrous iron transmembrane transport(GO:1903874) |
| 0.3 |
0.5 |
GO:0032423 |
regulation of mismatch repair(GO:0032423) |
| 0.3 |
0.8 |
GO:0002446 |
neutrophil mediated immunity(GO:0002446) |
| 0.3 |
1.6 |
GO:1902988 |
macrophage proliferation(GO:0061517) microglial cell proliferation(GO:0061518) regulation of neuronal signal transduction(GO:1902847) neurofibrillary tangle assembly(GO:1902988) regulation of neurofibrillary tangle assembly(GO:1902996) positive regulation of neurofibrillary tangle assembly(GO:1902998) |
| 0.3 |
0.3 |
GO:1904429 |
regulation of t-circle formation(GO:1904429) |
| 0.3 |
1.3 |
GO:0046598 |
positive regulation of viral entry into host cell(GO:0046598) |
| 0.3 |
2.0 |
GO:0018196 |
peptidyl-asparagine modification(GO:0018196) |
| 0.3 |
4.6 |
GO:0006829 |
zinc II ion transport(GO:0006829) |
| 0.3 |
1.0 |
GO:0034729 |
histone H3-K79 methylation(GO:0034729) |
| 0.3 |
0.3 |
GO:0045048 |
protein insertion into ER membrane(GO:0045048) |
| 0.3 |
0.3 |
GO:1903070 |
negative regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903070) |
| 0.3 |
3.8 |
GO:0038063 |
collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) collagen-activated signaling pathway(GO:0038065) |
| 0.3 |
1.0 |
GO:0071376 |
response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
| 0.3 |
2.3 |
GO:0015844 |
monoamine transport(GO:0015844) |
| 0.3 |
2.3 |
GO:0035269 |
protein O-linked mannosylation(GO:0035269) |
| 0.3 |
2.8 |
GO:0006828 |
manganese ion transport(GO:0006828) |
| 0.3 |
0.3 |
GO:2000398 |
regulation of T cell differentiation in thymus(GO:0033081) regulation of thymocyte aggregation(GO:2000398) |
| 0.3 |
1.0 |
GO:0002931 |
response to ischemia(GO:0002931) |
| 0.2 |
1.7 |
GO:0042126 |
nitrate metabolic process(GO:0042126) |
| 0.2 |
3.2 |
GO:0033344 |
cholesterol efflux(GO:0033344) |
| 0.2 |
2.0 |
GO:0006883 |
cellular sodium ion homeostasis(GO:0006883) |
| 0.2 |
0.5 |
GO:0021800 |
cerebral cortex tangential migration(GO:0021800) |
| 0.2 |
0.5 |
GO:0014022 |
neural plate elongation(GO:0014022) convergent extension involved in neural plate elongation(GO:0022007) |
| 0.2 |
0.2 |
GO:1904956 |
Wnt signaling pathway involved in somitogenesis(GO:0090244) regulation of midbrain dopaminergic neuron differentiation(GO:1904956) |
| 0.2 |
0.2 |
GO:0006990 |
positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response(GO:0006990) |
| 0.2 |
1.0 |
GO:0035752 |
lysosomal lumen pH elevation(GO:0035752) |
| 0.2 |
0.2 |
GO:0071947 |
protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
| 0.2 |
0.5 |
GO:0071225 |
cellular response to muramyl dipeptide(GO:0071225) |
| 0.2 |
1.4 |
GO:0045579 |
positive regulation of B cell differentiation(GO:0045579) |
| 0.2 |
1.7 |
GO:0042167 |
porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
| 0.2 |
1.2 |
GO:0046501 |
protoporphyrinogen IX metabolic process(GO:0046501) |
| 0.2 |
1.2 |
GO:0042743 |
hydrogen peroxide metabolic process(GO:0042743) |
| 0.2 |
1.9 |
GO:0007205 |
protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
| 0.2 |
0.2 |
GO:0003219 |
cardiac right ventricle formation(GO:0003219) |
| 0.2 |
14.5 |
GO:0016579 |
protein deubiquitination(GO:0016579) |
| 0.2 |
0.7 |
GO:0036228 |
protein targeting to nuclear inner membrane(GO:0036228) |
| 0.2 |
2.8 |
GO:2000060 |
positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000060) |
| 0.2 |
0.5 |
GO:1900119 |
positive regulation of execution phase of apoptosis(GO:1900119) |
| 0.2 |
3.0 |
GO:1902236 |
negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902236) |
| 0.2 |
1.6 |
GO:0097186 |
amelogenesis(GO:0097186) |
| 0.2 |
0.5 |
GO:0043589 |
skin morphogenesis(GO:0043589) |
| 0.2 |
0.2 |
GO:0060125 |
negative regulation of growth hormone secretion(GO:0060125) |
| 0.2 |
1.1 |
GO:0000480 |
endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000480) |
| 0.2 |
2.5 |
GO:1903301 |
positive regulation of glucokinase activity(GO:0033133) positive regulation of hexokinase activity(GO:1903301) |
| 0.2 |
0.2 |
GO:0001922 |
B-1 B cell homeostasis(GO:0001922) |
| 0.2 |
0.4 |
GO:0000291 |
nuclear-transcribed mRNA catabolic process, exonucleolytic(GO:0000291) |
| 0.2 |
0.9 |
GO:0006777 |
Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) |
| 0.2 |
2.2 |
GO:0031937 |
positive regulation of chromatin silencing(GO:0031937) |
| 0.2 |
2.9 |
GO:0070584 |
mitochondrion morphogenesis(GO:0070584) |
| 0.2 |
0.2 |
GO:1903630 |
regulation of aminoacyl-tRNA ligase activity(GO:1903630) positive regulation of aminoacyl-tRNA ligase activity(GO:1903632) |
| 0.2 |
0.7 |
GO:1902396 |
protein localization to bicellular tight junction(GO:1902396) |
| 0.2 |
1.1 |
GO:0000727 |
double-strand break repair via break-induced replication(GO:0000727) |
| 0.2 |
0.4 |
GO:1903895 |
negative regulation of IRE1-mediated unfolded protein response(GO:1903895) |
| 0.2 |
1.3 |
GO:0050820 |
positive regulation of coagulation(GO:0050820) |
| 0.2 |
0.7 |
GO:1903587 |
regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903587) |
| 0.2 |
7.8 |
GO:0050885 |
neuromuscular process controlling balance(GO:0050885) |
| 0.2 |
1.3 |
GO:0015858 |
nucleoside transport(GO:0015858) |
| 0.2 |
1.3 |
GO:1904217 |
regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) regulation of serine C-palmitoyltransferase activity(GO:1904220) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
| 0.2 |
4.1 |
GO:0021522 |
spinal cord motor neuron differentiation(GO:0021522) |
| 0.2 |
2.1 |
GO:0009072 |
aromatic amino acid family metabolic process(GO:0009072) |
| 0.2 |
4.3 |
GO:0060765 |
regulation of androgen receptor signaling pathway(GO:0060765) |
| 0.2 |
1.3 |
GO:1901534 |
positive regulation of hematopoietic progenitor cell differentiation(GO:1901534) |
| 0.2 |
1.1 |
GO:0006878 |
cellular copper ion homeostasis(GO:0006878) |
| 0.2 |
1.9 |
GO:0032418 |
lysosome localization(GO:0032418) |
| 0.2 |
0.6 |
GO:1902514 |
regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1902514) |
| 0.2 |
0.8 |
GO:0097646 |
calcitonin family receptor signaling pathway(GO:0097646) amylin receptor signaling pathway(GO:0097647) |
| 0.2 |
0.4 |
GO:0070234 |
positive regulation of T cell apoptotic process(GO:0070234) |
| 0.2 |
1.7 |
GO:2000096 |
positive regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000096) |
| 0.2 |
5.6 |
GO:0030641 |
regulation of cellular pH(GO:0030641) |
| 0.2 |
0.4 |
GO:0046952 |
ketone body catabolic process(GO:0046952) |
| 0.2 |
1.2 |
GO:0060712 |
spongiotrophoblast layer development(GO:0060712) |
| 0.2 |
0.6 |
GO:0061081 |
positive regulation of myeloid leukocyte cytokine production involved in immune response(GO:0061081) |
| 0.2 |
3.3 |
GO:0006904 |
vesicle docking involved in exocytosis(GO:0006904) |
| 0.2 |
0.4 |
GO:0006014 |
D-ribose metabolic process(GO:0006014) |
| 0.2 |
0.8 |
GO:0006561 |
proline biosynthetic process(GO:0006561) |
| 0.2 |
0.8 |
GO:1900368 |
regulation of RNA interference(GO:1900368) |
| 0.2 |
0.2 |
GO:0033006 |
regulation of mast cell activation involved in immune response(GO:0033006) regulation of mast cell degranulation(GO:0043304) |
| 0.2 |
0.4 |
GO:1903054 |
negative regulation of extracellular matrix organization(GO:1903054) |
| 0.2 |
1.2 |
GO:0070127 |
tRNA aminoacylation for mitochondrial protein translation(GO:0070127) |
| 0.2 |
2.6 |
GO:0042761 |
very long-chain fatty acid biosynthetic process(GO:0042761) |
| 0.2 |
0.6 |
GO:0046726 |
positive regulation by virus of viral protein levels in host cell(GO:0046726) |
| 0.2 |
0.4 |
GO:1901491 |
negative regulation of lymphangiogenesis(GO:1901491) |
| 0.2 |
2.4 |
GO:0050884 |
neuromuscular process controlling posture(GO:0050884) |
| 0.2 |
0.2 |
GO:0032328 |
alanine transport(GO:0032328) |
| 0.2 |
0.6 |
GO:0034398 |
telomere tethering at nuclear periphery(GO:0034398) meiotic telomere tethering at nuclear periphery(GO:0044821) meiotic attachment of telomere to nuclear envelope(GO:0070197) chromosome attachment to the nuclear envelope(GO:0097240) |
| 0.2 |
0.6 |
GO:0006103 |
2-oxoglutarate metabolic process(GO:0006103) |
| 0.2 |
1.4 |
GO:0021819 |
cerebral cortex radial glia guided migration(GO:0021801) layer formation in cerebral cortex(GO:0021819) telencephalon glial cell migration(GO:0022030) |
| 0.2 |
0.4 |
GO:0001845 |
phagolysosome assembly(GO:0001845) |
| 0.2 |
1.2 |
GO:0008228 |
opsonization(GO:0008228) |
| 0.2 |
0.6 |
GO:0070782 |
phosphatidylserine exposure on apoptotic cell surface(GO:0070782) |
| 0.2 |
0.6 |
GO:0019369 |
arachidonic acid metabolic process(GO:0019369) |
| 0.2 |
1.9 |
GO:0071470 |
cellular response to osmotic stress(GO:0071470) |
| 0.2 |
0.4 |
GO:0045342 |
MHC class II biosynthetic process(GO:0045342) regulation of MHC class II biosynthetic process(GO:0045346) |
| 0.2 |
0.4 |
GO:1900220 |
semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis(GO:1900220) |
| 0.2 |
0.4 |
GO:0002431 |
Fc receptor mediated stimulatory signaling pathway(GO:0002431) |
| 0.2 |
0.4 |
GO:0090286 |
cytoskeletal anchoring at nuclear membrane(GO:0090286) |
| 0.2 |
0.8 |
GO:0075044 |
autophagy of host cells involved in interaction with symbiont(GO:0075044) autophagy involved in symbiotic interaction(GO:0075071) |
| 0.2 |
0.6 |
GO:0010884 |
positive regulation of lipid storage(GO:0010884) |
| 0.2 |
2.1 |
GO:0001731 |
formation of translation preinitiation complex(GO:0001731) |
| 0.2 |
0.2 |
GO:0034122 |
negative regulation of toll-like receptor signaling pathway(GO:0034122) |
| 0.2 |
2.8 |
GO:1901017 |
negative regulation of potassium ion transmembrane transporter activity(GO:1901017) |
| 0.2 |
1.1 |
GO:0072656 |
maintenance of protein location in mitochondrion(GO:0072656) |
| 0.2 |
2.6 |
GO:0050905 |
neuromuscular process(GO:0050905) |
| 0.2 |
1.9 |
GO:0034314 |
Arp2/3 complex-mediated actin nucleation(GO:0034314) |
| 0.2 |
1.7 |
GO:0098787 |
mRNA cleavage involved in mRNA processing(GO:0098787) |
| 0.2 |
0.6 |
GO:0015882 |
L-ascorbic acid transport(GO:0015882) transepithelial L-ascorbic acid transport(GO:0070904) |
| 0.2 |
0.6 |
GO:0007183 |
SMAD protein complex assembly(GO:0007183) |
| 0.2 |
0.2 |
GO:0034454 |
microtubule anchoring at centrosome(GO:0034454) microtubule anchoring at microtubule organizing center(GO:0072393) |
| 0.2 |
0.4 |
GO:0030397 |
membrane disassembly(GO:0030397) nuclear envelope disassembly(GO:0051081) |
| 0.2 |
2.0 |
GO:0033539 |
fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
| 0.2 |
0.2 |
GO:0006198 |
cAMP catabolic process(GO:0006198) |
| 0.2 |
0.4 |
GO:0007217 |
tachykinin receptor signaling pathway(GO:0007217) |
| 0.2 |
0.9 |
GO:0031915 |
positive regulation of synaptic plasticity(GO:0031915) |
| 0.2 |
0.2 |
GO:0051014 |
actin filament severing(GO:0051014) |
| 0.2 |
0.2 |
GO:2000095 |
regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000095) |
| 0.2 |
2.9 |
GO:0034063 |
stress granule assembly(GO:0034063) |
| 0.2 |
0.4 |
GO:0015838 |
amino-acid betaine transport(GO:0015838) |
| 0.2 |
1.3 |
GO:0099601 |
regulation of neurotransmitter receptor activity(GO:0099601) |
| 0.2 |
0.5 |
GO:0006556 |
S-adenosylmethionine biosynthetic process(GO:0006556) |
| 0.2 |
1.1 |
GO:0097384 |
cellular lipid biosynthetic process(GO:0097384) |
| 0.2 |
0.4 |
GO:0071672 |
negative regulation of smooth muscle cell chemotaxis(GO:0071672) |
| 0.2 |
0.5 |
GO:0033578 |
protein glycosylation in Golgi(GO:0033578) |
| 0.2 |
0.4 |
GO:0015919 |
peroxisomal membrane transport(GO:0015919) protein import into peroxisome membrane(GO:0045046) |
| 0.2 |
0.5 |
GO:0031584 |
activation of phospholipase D activity(GO:0031584) |
| 0.2 |
0.9 |
GO:0045794 |
negative regulation of cell volume(GO:0045794) |
| 0.2 |
19.2 |
GO:0035023 |
regulation of Rho protein signal transduction(GO:0035023) |
| 0.2 |
2.1 |
GO:0090110 |
cargo loading into COPII-coated vesicle(GO:0090110) |
| 0.2 |
1.4 |
GO:0010225 |
response to UV-C(GO:0010225) |
| 0.2 |
1.6 |
GO:0060999 |
positive regulation of dendritic spine development(GO:0060999) |
| 0.2 |
4.0 |
GO:0006487 |
protein N-linked glycosylation(GO:0006487) |
| 0.2 |
0.2 |
GO:0060027 |
convergent extension involved in gastrulation(GO:0060027) |
| 0.2 |
0.5 |
GO:0030327 |
prenylated protein catabolic process(GO:0030327) |
| 0.2 |
0.5 |
GO:0097026 |
dendritic cell dendrite assembly(GO:0097026) |
| 0.2 |
0.3 |
GO:2000623 |
regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
| 0.2 |
1.2 |
GO:0030950 |
establishment or maintenance of actin cytoskeleton polarity(GO:0030950) |
| 0.2 |
0.7 |
GO:0072344 |
rescue of stalled ribosome(GO:0072344) |
| 0.2 |
0.5 |
GO:0000414 |
regulation of histone H3-K36 methylation(GO:0000414) |
| 0.2 |
0.5 |
GO:0032815 |
negative regulation of natural killer cell activation(GO:0032815) |
| 0.2 |
0.3 |
GO:0061462 |
protein localization to lysosome(GO:0061462) |
| 0.2 |
0.7 |
GO:0035754 |
B cell chemotaxis(GO:0035754) |
| 0.2 |
0.7 |
GO:0032929 |
negative regulation of superoxide anion generation(GO:0032929) |
| 0.2 |
5.3 |
GO:0030032 |
lamellipodium assembly(GO:0030032) |
| 0.2 |
1.7 |
GO:0048266 |
behavioral response to pain(GO:0048266) |
| 0.2 |
1.2 |
GO:0032095 |
regulation of response to food(GO:0032095) |
| 0.2 |
0.8 |
GO:0035280 |
miRNA loading onto RISC involved in gene silencing by miRNA(GO:0035280) |
| 0.2 |
0.7 |
GO:1901475 |
pyruvate transmembrane transport(GO:1901475) |
| 0.2 |
1.8 |
GO:0006610 |
ribosomal protein import into nucleus(GO:0006610) |
| 0.2 |
0.5 |
GO:0090557 |
establishment of endothelial intestinal barrier(GO:0090557) |
| 0.2 |
3.4 |
GO:0048536 |
spleen development(GO:0048536) |
| 0.2 |
2.1 |
GO:0000768 |
syncytium formation by plasma membrane fusion(GO:0000768) |
| 0.2 |
0.2 |
GO:0035927 |
RNA import into mitochondrion(GO:0035927) |
| 0.2 |
1.3 |
GO:0048268 |
clathrin coat assembly(GO:0048268) |
| 0.2 |
10.4 |
GO:0048814 |
regulation of dendrite morphogenesis(GO:0048814) |
| 0.2 |
0.3 |
GO:0090280 |
positive regulation of calcium ion import(GO:0090280) |
| 0.2 |
1.6 |
GO:0070940 |
dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
| 0.2 |
0.6 |
GO:0042256 |
mature ribosome assembly(GO:0042256) |
| 0.2 |
0.6 |
GO:2000561 |
CD4-positive, alpha-beta T cell proliferation(GO:0035739) negative regulation of alpha-beta T cell proliferation(GO:0046642) regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000561) negative regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000562) |
| 0.2 |
0.3 |
GO:0070814 |
hydrogen sulfide biosynthetic process(GO:0070814) |
| 0.2 |
3.0 |
GO:0008210 |
estrogen metabolic process(GO:0008210) |
| 0.2 |
1.1 |
GO:0000289 |
nuclear-transcribed mRNA poly(A) tail shortening(GO:0000289) |
| 0.2 |
0.6 |
GO:0007258 |
JUN phosphorylation(GO:0007258) |
| 0.2 |
1.4 |
GO:0006885 |
regulation of pH(GO:0006885) |
| 0.2 |
4.0 |
GO:0061014 |
positive regulation of mRNA catabolic process(GO:0061014) |
| 0.2 |
0.6 |
GO:0010756 |
positive regulation of plasminogen activation(GO:0010756) |
| 0.2 |
1.4 |
GO:0006613 |
cotranslational protein targeting to membrane(GO:0006613) |
| 0.2 |
0.9 |
GO:2001223 |
negative regulation of neuron migration(GO:2001223) |
| 0.2 |
0.5 |
GO:0035948 |
positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter(GO:0035948) regulation of cellular ketone metabolic process by positive regulation of transcription from RNA polymerase II promoter(GO:0072366) |
| 0.2 |
0.8 |
GO:0043653 |
mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
| 0.1 |
0.6 |
GO:0045002 |
double-strand break repair via single-strand annealing(GO:0045002) |
| 0.1 |
0.4 |
GO:0035234 |
ectopic germ cell programmed cell death(GO:0035234) |
| 0.1 |
1.0 |
GO:0032757 |
positive regulation of interleukin-8 production(GO:0032757) |
| 0.1 |
0.7 |
GO:2001023 |
regulation of response to drug(GO:2001023) |
| 0.1 |
0.6 |
GO:0010453 |
regulation of cell fate commitment(GO:0010453) |
| 0.1 |
0.9 |
GO:0090161 |
Golgi ribbon formation(GO:0090161) |
| 0.1 |
0.4 |
GO:0070944 |
neutrophil mediated killing of bacterium(GO:0070944) |
| 0.1 |
0.6 |
GO:0006531 |
aspartate metabolic process(GO:0006531) |
| 0.1 |
3.2 |
GO:0046460 |
triglyceride biosynthetic process(GO:0019432) neutral lipid biosynthetic process(GO:0046460) acylglycerol biosynthetic process(GO:0046463) |
| 0.1 |
0.3 |
GO:0071028 |
nuclear RNA surveillance(GO:0071027) nuclear mRNA surveillance(GO:0071028) |
| 0.1 |
0.4 |
GO:0045919 |
positive regulation of cytolysis(GO:0045919) |
| 0.1 |
1.3 |
GO:0007257 |
activation of JUN kinase activity(GO:0007257) |
| 0.1 |
0.4 |
GO:0046900 |
tetrahydrofolylpolyglutamate metabolic process(GO:0046900) |
| 0.1 |
0.4 |
GO:1900736 |
regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900736) positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900738) |
| 0.1 |
0.4 |
GO:0030157 |
pancreatic juice secretion(GO:0030157) |
| 0.1 |
0.1 |
GO:0048289 |
isotype switching to IgE isotypes(GO:0048289) regulation of isotype switching to IgE isotypes(GO:0048293) |
| 0.1 |
0.4 |
GO:0043116 |
negative regulation of vascular permeability(GO:0043116) |
| 0.1 |
1.9 |
GO:0006308 |
DNA catabolic process(GO:0006308) |
| 0.1 |
0.3 |
GO:0045792 |
negative regulation of cell size(GO:0045792) |
| 0.1 |
1.0 |
GO:0097352 |
autophagosome maturation(GO:0097352) |
| 0.1 |
0.3 |
GO:0050910 |
detection of mechanical stimulus involved in sensory perception of sound(GO:0050910) |
| 0.1 |
0.3 |
GO:0060330 |
regulation of response to interferon-gamma(GO:0060330) |
| 0.1 |
3.0 |
GO:0003333 |
amino acid transmembrane transport(GO:0003333) |
| 0.1 |
0.4 |
GO:0036233 |
glycine import(GO:0036233) |
| 0.1 |
0.1 |
GO:0006498 |
N-terminal protein lipidation(GO:0006498) |
| 0.1 |
0.3 |
GO:0097435 |
fibril organization(GO:0097435) |
| 0.1 |
3.5 |
GO:0007218 |
neuropeptide signaling pathway(GO:0007218) |
| 0.1 |
0.4 |
GO:0032026 |
response to magnesium ion(GO:0032026) |
| 0.1 |
0.4 |
GO:0001705 |
ectoderm formation(GO:0001705) |
| 0.1 |
1.5 |
GO:0034219 |
carbohydrate transmembrane transport(GO:0034219) |
| 0.1 |
0.1 |
GO:0060831 |
smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:0060831) |
| 0.1 |
0.4 |
GO:0043302 |
positive regulation of leukocyte degranulation(GO:0043302) |
| 0.1 |
1.4 |
GO:0042246 |
tissue regeneration(GO:0042246) |
| 0.1 |
0.5 |
GO:0032688 |
negative regulation of interferon-beta production(GO:0032688) |
| 0.1 |
0.2 |
GO:0042663 |
regulation of endodermal cell fate specification(GO:0042663) |
| 0.1 |
0.5 |
GO:0046475 |
glycerophospholipid catabolic process(GO:0046475) |
| 0.1 |
0.2 |
GO:2000418 |
positive regulation of eosinophil migration(GO:2000418) |
| 0.1 |
0.4 |
GO:2000645 |
negative regulation of receptor catabolic process(GO:2000645) |
| 0.1 |
0.1 |
GO:0003162 |
atrioventricular node development(GO:0003162) |
| 0.1 |
1.0 |
GO:0001675 |
acrosome assembly(GO:0001675) |
| 0.1 |
0.2 |
GO:0042989 |
sequestering of actin monomers(GO:0042989) |
| 0.1 |
3.5 |
GO:0006890 |
retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
| 0.1 |
0.8 |
GO:0014898 |
muscle hypertrophy in response to stress(GO:0003299) cardiac muscle hypertrophy in response to stress(GO:0014898) |
| 0.1 |
0.2 |
GO:0072378 |
blood coagulation, fibrin clot formation(GO:0072378) |
| 0.1 |
1.7 |
GO:0035970 |
peptidyl-threonine dephosphorylation(GO:0035970) |
| 0.1 |
0.2 |
GO:0019372 |
lipoxygenase pathway(GO:0019372) |
| 0.1 |
0.9 |
GO:0060219 |
camera-type eye photoreceptor cell differentiation(GO:0060219) |
| 0.1 |
0.7 |
GO:0036066 |
protein O-linked fucosylation(GO:0036066) |
| 0.1 |
0.5 |
GO:0060767 |
epithelial cell proliferation involved in prostate gland development(GO:0060767) |
| 0.1 |
1.9 |
GO:0051647 |
nucleus localization(GO:0051647) |
| 0.1 |
0.8 |
GO:1901078 |
negative regulation of relaxation of muscle(GO:1901078) |
| 0.1 |
0.2 |
GO:1903351 |
response to dopamine(GO:1903350) cellular response to dopamine(GO:1903351) |
| 0.1 |
0.5 |
GO:0032469 |
endoplasmic reticulum calcium ion homeostasis(GO:0032469) |
| 0.1 |
1.8 |
GO:0070828 |
heterochromatin organization(GO:0070828) |
| 0.1 |
0.8 |
GO:0006451 |
selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
| 0.1 |
0.9 |
GO:0032801 |
receptor catabolic process(GO:0032801) |
| 0.1 |
0.2 |
GO:0046104 |
thymidine metabolic process(GO:0046104) |
| 0.1 |
0.5 |
GO:0006655 |
phosphatidylglycerol biosynthetic process(GO:0006655) cardiolipin biosynthetic process(GO:0032049) |
| 0.1 |
1.1 |
GO:0006182 |
cGMP biosynthetic process(GO:0006182) |
| 0.1 |
0.3 |
GO:0061013 |
regulation of mRNA catabolic process(GO:0061013) |
| 0.1 |
0.5 |
GO:0014043 |
negative regulation of neuron maturation(GO:0014043) |
| 0.1 |
1.4 |
GO:0030521 |
androgen receptor signaling pathway(GO:0030521) |
| 0.1 |
0.6 |
GO:0009134 |
nucleoside diphosphate catabolic process(GO:0009134) |
| 0.1 |
1.2 |
GO:0033138 |
positive regulation of peptidyl-serine phosphorylation(GO:0033138) |
| 0.1 |
0.6 |
GO:0071354 |
cellular response to interleukin-6(GO:0071354) |
| 0.1 |
1.0 |
GO:0016191 |
synaptic vesicle uncoating(GO:0016191) |
| 0.1 |
0.7 |
GO:0048820 |
hair follicle maturation(GO:0048820) |
| 0.1 |
0.6 |
GO:0032094 |
response to food(GO:0032094) |
| 0.1 |
0.5 |
GO:2000819 |
regulation of nucleotide-excision repair(GO:2000819) |
| 0.1 |
0.1 |
GO:0007625 |
grooming behavior(GO:0007625) |
| 0.1 |
0.7 |
GO:0006884 |
cell volume homeostasis(GO:0006884) |
| 0.1 |
0.2 |
GO:0021886 |
hypothalamus gonadotrophin-releasing hormone neuron differentiation(GO:0021886) hypothalamus gonadotrophin-releasing hormone neuron development(GO:0021888) |
| 0.1 |
1.0 |
GO:2000369 |
regulation of clathrin-mediated endocytosis(GO:2000369) |
| 0.1 |
0.5 |
GO:0031295 |
T cell costimulation(GO:0031295) |
| 0.1 |
0.1 |
GO:0014887 |
cardiac muscle adaptation(GO:0014887) |
| 0.1 |
0.5 |
GO:1900095 |
regulation of dosage compensation by inactivation of X chromosome(GO:1900095) |
| 0.1 |
0.2 |
GO:0071034 |
CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
| 0.1 |
1.2 |
GO:0045761 |
regulation of adenylate cyclase activity(GO:0045761) |
| 0.1 |
0.2 |
GO:0010807 |
regulation of synaptic vesicle priming(GO:0010807) |
| 0.1 |
0.5 |
GO:0000393 |
spliceosomal conformational changes to generate catalytic conformation(GO:0000393) |
| 0.1 |
0.1 |
GO:0009794 |
regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
| 0.1 |
0.6 |
GO:0045907 |
positive regulation of vasoconstriction(GO:0045907) |
| 0.1 |
4.8 |
GO:0036503 |
ERAD pathway(GO:0036503) |
| 0.1 |
0.7 |
GO:0035887 |
aortic smooth muscle cell differentiation(GO:0035887) |
| 0.1 |
0.4 |
GO:1990090 |
response to nerve growth factor(GO:1990089) cellular response to nerve growth factor stimulus(GO:1990090) |
| 0.1 |
0.8 |
GO:0060294 |
cilium movement involved in cell motility(GO:0060294) |
| 0.1 |
0.4 |
GO:0043569 |
negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
| 0.1 |
0.3 |
GO:1903223 |
positive regulation of oxidative stress-induced neuron death(GO:1903223) positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903378) |
| 0.1 |
1.0 |
GO:0080171 |
lysosome organization(GO:0007040) lytic vacuole organization(GO:0080171) |
| 0.1 |
2.4 |
GO:0071347 |
cellular response to interleukin-1(GO:0071347) |
| 0.1 |
0.1 |
GO:0051956 |
negative regulation of amino acid transport(GO:0051956) |
| 0.1 |
1.0 |
GO:0000188 |
inactivation of MAPK activity(GO:0000188) |
| 0.1 |
0.4 |
GO:0007033 |
vacuole organization(GO:0007033) |
| 0.1 |
0.9 |
GO:0035414 |
negative regulation of catenin import into nucleus(GO:0035414) |
| 0.1 |
0.7 |
GO:2000051 |
negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
| 0.1 |
0.2 |
GO:0030948 |
negative regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030948) |
| 0.1 |
0.4 |
GO:0050995 |
negative regulation of lipid catabolic process(GO:0050995) |
| 0.1 |
1.2 |
GO:0006891 |
intra-Golgi vesicle-mediated transport(GO:0006891) |
| 0.1 |
0.4 |
GO:0031848 |
protection from non-homologous end joining at telomere(GO:0031848) |
| 0.1 |
0.3 |
GO:0071397 |
cellular response to cholesterol(GO:0071397) |
| 0.1 |
1.0 |
GO:0002504 |
antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002504) |
| 0.1 |
0.3 |
GO:0071361 |
cellular response to ethanol(GO:0071361) |
| 0.1 |
0.1 |
GO:0060681 |
branch elongation involved in ureteric bud branching(GO:0060681) |
| 0.1 |
0.2 |
GO:0019227 |
neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
| 0.1 |
1.3 |
GO:0042178 |
xenobiotic catabolic process(GO:0042178) |
| 0.1 |
0.2 |
GO:0006931 |
substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
| 0.1 |
0.7 |
GO:0031998 |
regulation of fatty acid beta-oxidation(GO:0031998) |
| 0.1 |
0.3 |
GO:0051601 |
exocyst localization(GO:0051601) |
| 0.1 |
1.1 |
GO:0032728 |
positive regulation of interferon-beta production(GO:0032728) |
| 0.1 |
0.2 |
GO:0015712 |
hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
| 0.1 |
0.2 |
GO:1902414 |
protein localization to cell junction(GO:1902414) |
| 0.1 |
0.6 |
GO:0015074 |
DNA integration(GO:0015074) |
| 0.1 |
0.1 |
GO:0006041 |
glucosamine metabolic process(GO:0006041) |
| 0.1 |
0.1 |
GO:0001575 |
globoside metabolic process(GO:0001575) |
| 0.1 |
0.1 |
GO:0045974 |
miRNA mediated inhibition of translation(GO:0035278) negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
| 0.1 |
0.9 |
GO:0010758 |
regulation of macrophage chemotaxis(GO:0010758) |
| 0.1 |
0.6 |
GO:0009268 |
response to pH(GO:0009268) |
| 0.1 |
0.8 |
GO:0043374 |
CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
| 0.1 |
0.3 |
GO:1902042 |
negative regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902042) |
| 0.1 |
1.3 |
GO:0031648 |
protein destabilization(GO:0031648) |
| 0.1 |
5.7 |
GO:0051607 |
defense response to virus(GO:0051607) |
| 0.1 |
0.2 |
GO:1901655 |
cellular response to ketone(GO:1901655) |
| 0.1 |
0.3 |
GO:0035902 |
response to immobilization stress(GO:0035902) |
| 0.1 |
0.3 |
GO:0034975 |
protein folding in endoplasmic reticulum(GO:0034975) |
| 0.1 |
0.2 |
GO:1900060 |
negative regulation of sphingolipid biosynthetic process(GO:0090155) cellular sphingolipid homeostasis(GO:0090156) negative regulation of ceramide biosynthetic process(GO:1900060) |
| 0.1 |
0.2 |
GO:0006428 |
isoleucyl-tRNA aminoacylation(GO:0006428) |
| 0.1 |
0.1 |
GO:0030497 |
fatty acid elongation(GO:0030497) |
| 0.1 |
6.0 |
GO:0006813 |
potassium ion transport(GO:0006813) |
| 0.1 |
0.3 |
GO:0033198 |
response to ATP(GO:0033198) |
| 0.1 |
0.5 |
GO:0006054 |
N-acetylneuraminate metabolic process(GO:0006054) |
| 0.1 |
0.4 |
GO:0002051 |
osteoblast fate commitment(GO:0002051) |
| 0.1 |
0.5 |
GO:0000132 |
establishment of mitotic spindle orientation(GO:0000132) |
| 0.1 |
0.2 |
GO:0002024 |
diet induced thermogenesis(GO:0002024) |
| 0.1 |
0.4 |
GO:0071557 |
histone H3-K27 demethylation(GO:0071557) |
| 0.1 |
0.1 |
GO:1901421 |
positive regulation of response to alcohol(GO:1901421) |
| 0.1 |
1.0 |
GO:0006744 |
ubiquinone biosynthetic process(GO:0006744) quinone biosynthetic process(GO:1901663) |
| 0.1 |
0.1 |
GO:0021626 |
hindbrain maturation(GO:0021578) central nervous system maturation(GO:0021626) |
| 0.1 |
0.7 |
GO:0006268 |
DNA unwinding involved in DNA replication(GO:0006268) |
| 0.1 |
0.9 |
GO:1901264 |
carbohydrate derivative transport(GO:1901264) |
| 0.1 |
0.1 |
GO:0010847 |
regulation of chromatin assembly(GO:0010847) |
| 0.1 |
0.5 |
GO:2001273 |
regulation of glucose import in response to insulin stimulus(GO:2001273) |
| 0.1 |
0.2 |
GO:0043312 |
neutrophil degranulation(GO:0043312) |
| 0.1 |
0.2 |
GO:0002143 |
tRNA wobble position uridine thiolation(GO:0002143) |
| 0.1 |
1.9 |
GO:0048813 |
dendrite morphogenesis(GO:0048813) |
| 0.1 |
0.4 |
GO:0035646 |
endosome to melanosome transport(GO:0035646) endosome to pigment granule transport(GO:0043485) pigment granule maturation(GO:0048757) |
| 0.1 |
0.1 |
GO:0019919 |
peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) peptidyl-arginine omega-N-methylation(GO:0035247) |
| 0.1 |
0.2 |
GO:0006481 |
C-terminal protein methylation(GO:0006481) |
| 0.1 |
0.4 |
GO:0001505 |
regulation of neurotransmitter levels(GO:0001505) |
| 0.1 |
4.7 |
GO:0006836 |
neurotransmitter transport(GO:0006836) |
| 0.1 |
0.1 |
GO:0046909 |
intermembrane transport(GO:0046909) protein transport from ciliary membrane to plasma membrane(GO:1903445) |
| 0.1 |
0.1 |
GO:0002043 |
blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:0002043) |
| 0.1 |
1.5 |
GO:0000413 |
protein peptidyl-prolyl isomerization(GO:0000413) |
| 0.1 |
0.4 |
GO:0051292 |
nuclear pore complex assembly(GO:0051292) |
| 0.1 |
0.2 |
GO:0046967 |
cytosol to ER transport(GO:0046967) |
| 0.1 |
0.1 |
GO:1903847 |
regulation of aorta morphogenesis(GO:1903847) positive regulation of aorta morphogenesis(GO:1903849) |
| 0.1 |
0.6 |
GO:0034551 |
respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
| 0.1 |
0.2 |
GO:0030320 |
cellular anion homeostasis(GO:0030002) cellular monovalent inorganic anion homeostasis(GO:0030320) |
| 0.1 |
0.5 |
GO:0046827 |
positive regulation of protein export from nucleus(GO:0046827) |
| 0.1 |
0.4 |
GO:0055059 |
asymmetric neuroblast division(GO:0055059) |
| 0.1 |
0.2 |
GO:0030242 |
pexophagy(GO:0030242) |
| 0.1 |
0.5 |
GO:0044804 |
nucleophagy(GO:0044804) |
| 0.1 |
0.4 |
GO:0006390 |
transcription from mitochondrial promoter(GO:0006390) |
| 0.1 |
0.8 |
GO:0006383 |
transcription from RNA polymerase III promoter(GO:0006383) |
| 0.1 |
0.1 |
GO:0002925 |
positive regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002925) |
| 0.1 |
0.4 |
GO:0045602 |
negative regulation of endothelial cell differentiation(GO:0045602) |
| 0.1 |
0.1 |
GO:0006515 |
misfolded or incompletely synthesized protein catabolic process(GO:0006515) |
| 0.1 |
0.1 |
GO:0051481 |
negative regulation of cytosolic calcium ion concentration(GO:0051481) |
| 0.1 |
0.1 |
GO:0043030 |
regulation of macrophage activation(GO:0043030) |
| 0.1 |
0.5 |
GO:0000002 |
mitochondrial genome maintenance(GO:0000002) |
| 0.1 |
0.5 |
GO:0097205 |
renal filtration(GO:0097205) |
| 0.1 |
0.3 |
GO:0031936 |
negative regulation of chromatin silencing(GO:0031936) |
| 0.0 |
0.2 |
GO:0046684 |
response to pyrethroid(GO:0046684) |
| 0.0 |
1.4 |
GO:0007029 |
endoplasmic reticulum organization(GO:0007029) |
| 0.0 |
0.1 |
GO:0000448 |
cleavage in ITS2 between 5.8S rRNA and LSU-rRNA of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000448) |
| 0.0 |
0.1 |
GO:0048278 |
vesicle docking(GO:0048278) |
| 0.0 |
0.1 |
GO:0021554 |
optic nerve development(GO:0021554) |
| 0.0 |
0.1 |
GO:0019240 |
citrulline biosynthetic process(GO:0019240) |
| 0.0 |
0.4 |
GO:0070475 |
rRNA base methylation(GO:0070475) |
| 0.0 |
0.0 |
GO:0045776 |
negative regulation of blood pressure(GO:0045776) |
| 0.0 |
0.1 |
GO:0008206 |
bile acid metabolic process(GO:0008206) |
| 0.0 |
0.0 |
GO:0006984 |
ER-nucleus signaling pathway(GO:0006984) |
| 0.0 |
0.6 |
GO:0099517 |
anterograde synaptic vesicle transport(GO:0048490) synaptic vesicle cytoskeletal transport(GO:0099514) synaptic vesicle transport along microtubule(GO:0099517) |
| 0.0 |
0.2 |
GO:0005980 |
polysaccharide catabolic process(GO:0000272) glycogen catabolic process(GO:0005980) glucan catabolic process(GO:0009251) cellular polysaccharide catabolic process(GO:0044247) |
| 0.0 |
0.1 |
GO:0042402 |
histamine metabolic process(GO:0001692) amine catabolic process(GO:0009310) cellular biogenic amine catabolic process(GO:0042402) |
| 0.0 |
0.4 |
GO:0009615 |
response to virus(GO:0009615) |
| 0.0 |
0.3 |
GO:0006370 |
7-methylguanosine mRNA capping(GO:0006370) |
| 0.0 |
0.2 |
GO:1902775 |
mitochondrial large ribosomal subunit assembly(GO:1902775) |
| 0.0 |
0.1 |
GO:0042726 |
flavin-containing compound metabolic process(GO:0042726) |
| 0.0 |
0.0 |
GO:1900372 |
negative regulation of nucleotide biosynthetic process(GO:0030809) negative regulation of purine nucleotide biosynthetic process(GO:1900372) |
| 0.0 |
0.2 |
GO:0009235 |
cobalamin metabolic process(GO:0009235) |
| 0.0 |
0.1 |
GO:0036265 |
RNA (guanine-N7)-methylation(GO:0036265) |
| 0.0 |
0.1 |
GO:0061511 |
centriole elongation(GO:0061511) |
| 0.0 |
0.2 |
GO:2000114 |
regulation of establishment of cell polarity(GO:2000114) |
| 0.0 |
1.8 |
GO:0010923 |
negative regulation of phosphatase activity(GO:0010923) |
| 0.0 |
0.5 |
GO:0030835 |
negative regulation of actin filament depolymerization(GO:0030835) |
| 0.0 |
0.1 |
GO:0006657 |
CDP-choline pathway(GO:0006657) |
| 0.0 |
0.1 |
GO:1904424 |
regulation of GTP binding(GO:1904424) |
| 0.0 |
0.1 |
GO:0045056 |
transcytosis(GO:0045056) |
| 0.0 |
0.2 |
GO:0032148 |
activation of protein kinase B activity(GO:0032148) |
| 0.0 |
0.3 |
GO:0045824 |
negative regulation of innate immune response(GO:0045824) |
| 0.0 |
0.1 |
GO:0048311 |
mitochondrion distribution(GO:0048311) |
| 0.0 |
0.3 |
GO:0030262 |
apoptotic nuclear changes(GO:0030262) |
| 0.0 |
0.2 |
GO:0042574 |
retinal metabolic process(GO:0042574) |
| 0.0 |
0.2 |
GO:0010457 |
centriole-centriole cohesion(GO:0010457) |
| 0.0 |
0.2 |
GO:0051770 |
positive regulation of nitric-oxide synthase biosynthetic process(GO:0051770) |
| 0.0 |
0.7 |
GO:0061512 |
protein localization to cilium(GO:0061512) |
| 0.0 |
0.2 |
GO:0010606 |
positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
| 0.0 |
0.3 |
GO:0000288 |
nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:0000288) |
| 0.0 |
0.5 |
GO:0000038 |
very long-chain fatty acid metabolic process(GO:0000038) |
| 0.0 |
0.2 |
GO:0007289 |
spermatid nucleus differentiation(GO:0007289) |
| 0.0 |
0.1 |
GO:0016561 |
protein import into peroxisome matrix, translocation(GO:0016561) |
| 0.0 |
0.1 |
GO:0046604 |
positive regulation of mitotic centrosome separation(GO:0046604) |
| 0.0 |
0.9 |
GO:0000045 |
autophagosome assembly(GO:0000045) |
| 0.0 |
0.1 |
GO:0015014 |
heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
| 0.0 |
0.3 |
GO:0060292 |
long term synaptic depression(GO:0060292) |
| 0.0 |
0.0 |
GO:0042364 |
water-soluble vitamin biosynthetic process(GO:0042364) |
| 0.0 |
0.2 |
GO:0061050 |
regulation of cell growth involved in cardiac muscle cell development(GO:0061050) |
| 0.0 |
0.3 |
GO:0030517 |
negative regulation of axon extension(GO:0030517) |
| 0.0 |
0.1 |
GO:0002347 |
response to tumor cell(GO:0002347) |
| 0.0 |
0.1 |
GO:0010793 |
regulation of mRNA export from nucleus(GO:0010793) |
| 0.0 |
0.1 |
GO:0002021 |
response to dietary excess(GO:0002021) |
| 0.0 |
0.1 |
GO:0016255 |
attachment of GPI anchor to protein(GO:0016255) |
| 0.0 |
0.0 |
GO:0051823 |
regulation of synapse structural plasticity(GO:0051823) |
| 0.0 |
0.0 |
GO:0008295 |
spermidine biosynthetic process(GO:0008295) |
| 0.0 |
1.2 |
GO:0042787 |
protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0042787) |
| 0.0 |
0.0 |
GO:1901856 |
negative regulation of cellular respiration(GO:1901856) |
| 0.0 |
0.1 |
GO:0032212 |
positive regulation of telomere maintenance via telomerase(GO:0032212) |
| 0.0 |
0.0 |
GO:0071624 |
positive regulation of granulocyte chemotaxis(GO:0071624) positive regulation of neutrophil chemotaxis(GO:0090023) |
| 0.0 |
0.4 |
GO:0009062 |
fatty acid catabolic process(GO:0009062) |
| 0.0 |
0.1 |
GO:0070131 |
positive regulation of mitochondrial translation(GO:0070131) |
| 0.0 |
0.0 |
GO:1904715 |
negative regulation of chaperone-mediated autophagy(GO:1904715) |
